Skip to content
naulon

No retraction, correction or concern found when last checked on Oct 19, 2026.

Marine Drugs from Sponge-Microbe Association—A Review

Tresa Remya A. Thomas, Devanand P. Kavlekar, Ponnapakkam A. LokaBharathi

Marine Drugs · 2010 · Review · CC BY

doi:10.3390/md8041417

Abstract

The subject of this review is the biodiversity of marine sponges and associated microbes which have been reported to produce therapeutically important compounds, along with the contextual information on their geographic distribution. Class Demospongiae and the orders Halichondrida, Poecilosclerida and Dictyoceratida are the richest sources of these compounds. Among the microbial associates, members of the bacterial phylum Actinobacteria and fungal division Ascomycota have been identified to be the dominant producers of therapeutics. Though the number of bacterial associates outnumber the fungal associates, the documented potential of fungi to produce clinically active compounds is currently more important than that of bacteria. Interestingly, production of a few identical compounds by entirely different host-microbial associations has been detected in both terrestrial and marine environments. In the Demospongiae, microbial association is highly specific and so to the production of compounds. Besides, persistent production of bioactive compounds has also been encountered in highly specific host-symbiont associations. Though spatial and temporal variations are known to have a marked effect on the quality and quantity of bioactive compounds, only a few studies have covered these dimensions. The need to augment production of these compounds through tissue culture and mariculture has also been stressed. The reviewed database of these compounds is available at www.niobioinformatics.in/drug.php.

Full text

From PubMed Central, U.S. National Library of Medicine, as current on Oct 19, 2026. Paragraph numbers are ours, so an answer can point at one.

1. Introduction

Sponges (Phylum: Porifera) are evolutionarily ancient metazoans that have existed for 700–800 million years. They not only populate the tropical oceans in great abundance but also occur in temperate waters and even in freshwater. Marine sponges are widely distributed from intertidal zones to thousands of meters deep in the ocean. They are simple multicellular invertebrates attached to solid substrates in benthic habitats. Sponges are filter feeders, having numerous tiny pores on their surface, which allow water to enter and circulate through a series of canals where microorganisms and organic particles are filtered out and eaten. There are mainly three classes of sponges, namely the Calcarea (five orders and 24 families), Demospongiae (15 orders and 92 families) and Hexactinellida (six orders and 20 families). So far about 15,000 species of sponges have been described, but their true diversity may be higher. Most of them occur in the marine environment and only about 1% inhabit freshwater. Most of the species are placed under the class Demospongiae. Since sponges are simple and sessile organisms; during evolution they have developed potent chemical defensive mechanism to protect themselves from competitors and predators as well as infectious microorganisms. Studies show that secondary metabolites in sponges play a crucial role in their survival in the marine ecosystem. These natural products have interesting biomedical potential, pharmaceutical relevance and diverse biotechnological applications. The biomedical and pharmaceutical importances of these compounds are attributed to their antiviral, antitumor, antimicrobial and general cytotoxic properties. Interestingly, out of the 13 marine natural products that are currently under clinical trials as new drug candidates, 12 are derived from invertebrates. Among them, Porifera remains the most important phylum, as it provides a greater number of natural products, especially novel pharmacologically active compounds. Biochemical characteristics seem to be useful taxonomic markers and good indicators of sponge phylogeny. The diversity of biochemical properties of sponges has been demonstrated by the continued discovery of novel compounds, having pharmacological properties. These investigations started with the pioneering work of Bergmann on the extraction of novel bioactive nucleosides from the sponge Tectitethya crypta (formerly Cryptotethya crypta). The chemical diversity of secondary metabolites isolated from sponges includes amino acids, nucleosides, macrolides, porphyrins, terpenoids, aliphatic cyclic peroxides and sterols. Sponges are well known to be hosts for a large community of microorganisms, which comprise a significant percentage (up to 50–60%) of the biomass of the sponge host. The role of these diverse microbes in sponge biology varies from source of nutrition to mutualistic symbiosis with the sponge. Based on bacterial community studies employing molecular methods such as Denaturing Gradient Gel Electrophoresis (DGGE), 16S rRNA gene sequencing and Fluorescence In Situ Hybridization (FISH), it has been recognized that the sponge-associated bacterial community consists of at least ten bacterial phyla such as Proteobacteria, Nitrospira, Cyanobacteria, Bacteriodetes, Actinobacteria, Chloroflexi, Planctomycetes, Acidobacteria, Poribacteria and Verrucomicrobia besides members of the domain Archaea. Other symbiotic microbial populations that inhabit sponges are fungi and microalgae. Little is known about viruses in sponges, although virus-like particles have been observed in cell nuclei of Aplysina (Verongia) cavernicola. There are two pathways through which a developing sponge acquires bacterial symbionts. The first one is by selective absorption of specific bacteria from the large diversity of bacteria in the surrounding water column that passes through the sponge during filter feeding. The second one is by vertical transmission of symbionts through the gametes of the sponge by inclusion of the bacteria in the oocytes or larvae.

Symbiotic functions that have been attributed to microbial associates include nutrient acquisition, stabilization of sponge skeleton, processing of metabolic waste and secondary metabolite production. It is hypothesized that symbiotic marine microorganism harboured by sponges are the original producers of these bioactive compounds. The first experimental evidence supporting this hypothesis was derived from the work of Faulkner et al., who investigated the localization of natural products within sponge-microorganism association. For this purpose, cell populations within sponge samples were separated by differential centrifugation and the fractions obtained were analyzed chemically. By this approach, it was possible to locate the cytotoxic macrolide swinholide A and the peptide theopalauamide in the heterotrophic unicellular bacteria and in the filamentous heterotrophic bacteria, respectively. Both the bacterial strains were isolated from the sponge Theonella swinhoei.

Microbial associates of sponges gained significance as source of bioactive compounds only when a remarkable similarity was found between those compounds isolated predominantly from sponges and those found in terrestrial organism of entirely different taxa. Likewise, similarities between the structures of mycalamide A & B from the marine sponge Mycale hentscheli, collected in Dunedin Harbour (New Zealand) and pederin, a toxin originally isolated from the Paederus beetle in South America was recognized by Perry et al.. Mycalamides have been reported to be potent inhibitors of protein synthesis and were recently found to cause apoptosis. Thus, it indicates that at least some of the bioactive secondary metabolites isolated from sponges are produced by functional enzyme clusters, originated from the sponges and/or their associated microorganisms. It is now known that polybrominated biphenyl ether antibiotics isolated from the sponge Dysidea herbacea (Demospongiae) are actually produced by the endosymbiotic cyanobacterium Oscillatoria spongeliae. Molecular methods (e.g; rDNA, DGGE and FISH) have revealed the association of a variety of unculturable bacteria and Archaea in sponges. It has recently been demonstrated that sponge isolates with antimicrobial activity are numerically very abundant in the genus Pseudoalteromonas and the group of α-Proteobacteria and Actinobacteria. As infectious microorganisms evolve and develop resistance to existing pharmaceuticals, marine sponges provide novel leads against bacterial, viral, fungal and parasitic diseases. Thus, it is extremely relevant to highlight the therapeutic properties of various secondary metabolites synthesized by the microbial flora inhabiting sponges. In this review, an effort has been made to relate the biomedical significance of secondary metabolites of sponge-microbial association, which were discovered so far and their richness in different sponge taxa. It is also important to understand their ecological distribution in space and time so as to enable harnessing these compounds in an optimal and sustainable manner.

No bioactive compounds have been reported from microbes associated with sponge families such as Agelasidae, Astroscleridae, Calthropellidae, Geodiidae, Pachastrellidae, Thrombidae, Dictyodendrillidae, Acanthochaetetidae, Alectonidae, Hemiasterellidae, Placospongiidae, Polymastiidae, Spirastrellidae, Stylocordylidae, Tethyidae, Timeidae, Trachycladidae, Bubaridae, Dictyonellidae, Heteroxyidae, Halisarcidae, Calcifibrospongiidae, Phloeodictyidae, Lubomirskiidae, Malawispongiidae, Metaniidae, Metschnikowiidae, Palaeospongillidae, Potamolepiidae, Spongillidae, Spongillina incertae sedis, Plakinidae, Azoricidae, Corallistidae, Desmanthidae, Isoraphiniidae, Lithistida incertae sedis, Macandrewiidae, Phymaraphiniidae, Phymatellidae, Pleromidae, Scleritodermidae, Siphonidiidae, Vetulinidae, Latrunculiidae, Microcionidae, Rhabderemiidae, Cladorhizidae, Desmacellidae, Esperiopsidae, Guitarridae, Hamacanthidae, Merliidae, Podospongiidae, Chondropsidae, Coelosphaeridae, Crambeidae, Crellidae, Dendoricellidae, Desmacididae, Hymedesmiidae, Iotrochotidae, Phellodermidae, Tedaniidae, Samidae and Spirasigmidae of the class Demospongiae; Baeriidae, Lepidoleuconidae, Trichogypsiidae, Achramorphidae, Amphoriscidae, Grantiidae, Heteropiidae, Jenkinidae, Lelapiidae, Leucosoleniidae, Sycanthidae, Sycettidae, Minchinellidae, Petrobionidae, Clathrinida incertae sedis, Clathrinidae, Leucaltidae, Leucascidae, Levinellidae, Soleneiscidae, Lelapiellidae, Murrayonidae, Paramurrayonidae of the class Calcarea. There are no reports of microbially originated bioactive compounds from the class Hexactinellida.

2.1.1. Order: Astrophorida

Family: Ancorinidae

l,l-Diketopiperazine known as cyclo-(l-Pro-l-Phe), showing moderate antimicrobial activity was isolated from the bacterium Alcaligenes faecalis A72, which was found in association with the South China Sea sponge Stelletta tenuis. The sponge Stelletta tenuis is known for harbouring large number of cultivable bacterial diversity, including α-, γ-, δ-Proteobacteria, Bacteroidetes, Firmicutes and Actinobacteria. A marine fungus of the class Hyphomycetes was isolated from the Indo-Pacific sponge Jaspis aff. johnstoni. Fermentation of this marine culture led to the isolation of the tricyclic sesquiterpenes coriolin B, dihydrocoriolin C as well as the novel chloriolines A-C. Coriolin B and dihydrocoriolin C were earlier isolated from the terrestrial wood-rotting basidiomycete Coriolus consors. Coriolin B exhibited strong inhibition of human breast and CNS cell lines with IC50 values of 0.7 μg (breast) and 0.5 μg (neuroblastoma).

2.1.2. Order: Chondrosida

Family: Chondrillidae

Seven new fungal polyketides were isolated from the mycelium extract of the fungus Penicillium rugulosum, derived from the sponge Chondrosia reniformis (Elba, Italy). They include prugosenes A1–A3, B1, B2, C1 and C2. These compounds can be used as templates for new anti-infectives.

2.1.3. Order: Dendroceratida

Family: Darwinellidae

The sponge Dendrilla nigra is a rich source of cultivable marine actinomycetes. Investigations on a sponge specimen collected from the Vizhinjam coast (west coast of India) revealed that Micromonospora-Saccharomonospora-Streptomyces group was the major cultivable actinobacteria found in the sponge. The species Streptomyces dendra sp. nov. MSI051 isolated from Dendrilla nigra from the same coast exhibited a broad spectrum of antibacterial activity. The host sponge, as well as the associated bacterial symbiont MSI051, contained high levels of PLA2 (Phospholipase A2). Since PLA2 is a well-established antibacterial protein in the defense system of higher animals, its presence in the sponge-associated bacteria may indicate an integrated functional role in the host defense system. Another strain, Streptomyces sp. BLT7 isolated from Dendrilla nigra obtained from Kanyakumari (south east coast of India) also showed potential antibacterial activity in their extracellular products. A number of actinobacterial strains were also obtained from Dendrilla nigra, collected from the southwest coast of India. Among eleven heterotrophic actinobacteria isolated from one specimen, Nocardiopsis dassonvillei MAD08 was prominent in its antibacterial and anticandidal activity against the multidrug resistant pathogenic microbial strains. The antibacterial activity was assigned to the presence of 11 compounds and the anticandidal activity to a single protein. The uniqueness of this strain is reflected in the expression of both organic solvent (antibacterial) and water soluble (antifungal) antimicrobial compounds. In future, this may lead the way towards large-scale profitable production of antimicrobials from Nocardiopsis dassonvillei MAD08. The above studies reflect the consistent production of antimicrobial compounds by the actinobacteria harbouring individuals of Dendrilla nigra from south west coast of India.

2.1.4.1. Family: Dysideidae

Many marine sponges, especially the tropical ones, form symbioses with algae and often become net primary producers. Although associations with cyanobacteria are the most common, such partnership has also been observed with chlorophytes, rhodophytes, dinoflagellates and diatoms. A variety of marine sponges hold cyanobacteria as autotrophic symbionts, which are known to contribute to nutrition of host through extracellular lysis and phagocytosis, with possible glycogen reutilization by sponge cells. Cyanobacteria transfer glycerol and organic phosphate to sponge tissue, as derivatives of these compounds are known to support several basic metabolic pathways. Moreover, symbiotic cyanobacteria appear to be capable of fixing nitrogen. The tropical marine shallow water sponge Lamellodysidea herbacea (formerly Dysidea herbacea) which is common throughout the Indo-Pacific, is always found to harbour filamentous non-heterocystous cyanobacterium Oscillatoria spongeliae. It occurs intercellularly in large numbers up to 20% of the symbiotic associations’ volume and 30–50% of the sponge tissue volume. These cyanobacterial symbionts have been reported to be responsible for the production of a wide array of secondary metabolites by the sponge. Nuclear magnetic resonance analysis of the symbiont cell preparations from the specimen of Lamellodysidea herbacea obtained from Great Barrier Reef, Australia showed that they usually contain the chlorinated diketopiperazines, dihydrodysamide C and didechlorodihydrodysamide C, which are characteristic metabolites of the sponge-symbiont association. Since diketopiperazines (DKPs) are a common motif in various biologically active natural products, they may be useful scaffolds for the rational design of receptor probes and therapeutic agents. Symbiotic microorganisms of Dysidea sp. can synthesize physiologically active compounds which belong to the group of brominated diphenyl ethers. Vibrio sp. associated with Dysidea specimen collected near the islands of Tutuila and Ofu (Eastern Samoa) synthesize cytotoxic and antibacterial tetrabromodiphenyl ethers. A specimen of Lamellodysidea herbacea collected from the Republic of Palau (Caroline Island, Western Pacific Ocean) yielded a polybrominated biphenyl ether such as 2-(2′,4′-dibromophenyl)-4,6-dibromophenol. The compound was deposited as conspicuous crystals throughout the sponge tissue. The cyanobacteria Oscillatoria spongeliae was also observed as endosymbiont in the sponge mesohyl. They were separated from the sponge cells and heterotrophic bacteria by flow cytometry. Coupled gas chromatography-mass spectrometry and protein nuclear magnetic resonance revealed that the real source of the compound was the cyanobacteria Oscillatoria spongeliae. The polybrominated metabolites produced by the cyanobacteria are excreted into the surrounding aqueous medium in which they are not soluble, and therefore crystallize. Thus considerable amount of brominated metabolites are seen as crystalline material in the sponge mesohyl, with only a relatively small amount in the cyanobacteria. Polybrominated biphenyl ethers from Lamellodysidea herbacea are active against both Gram-, Gram+ bacteria and unicellular marine cyanobacteria. The compound, 2-(2′,4′-dibromophenyl)-4,6-dibromophenol showed antibacterial activity against Staphylococcus aureus, Escherichia coli, Bacillus subtilis etc. The apparent general toxicity of polybrominated compounds particularly to prokaryotes is beneficial to the association Lamellodysidea herbacea-Oscillatoria spongeliae. This association is more resistant to these compounds. Lamellodysidea herbacea is one of the established model systems for addressing the question as to whether sponge metabolites are produced by the symbiotic bacterium or the host itself. An unknown bacterium associated with the marine sponge Dysidea avara, collected from Adriatic Sea was found to produce the compound 2-methylthio-1,4-naphthoquinone. This compound showed strong antiangiogenic and antimicrobial properties. 16S rDNA analysis revealed that the bacterial strain shares 99% identity to the α-Proteobacteria MBIC3368.

2.1.4.2. Family: Irciniidae

Marine sponges in the genus Ircinia are known to be good sources of secondary metabolites having biological activities. The species Ircinia fasciculata, collected from the shallow coastal habitats of the Mediterranean Sea (~15 m depth) showed antimicrobial activity in the agar media inoculated with different indicator organisms such as Escherichia coli, Staphylococcus lentus, Candida sp., Bacillus subtilis and Mycobacterium sp. The sponge specimen was chosen for the isolation of bacteria, on the basis of the accumulated evidence that microorganism could well be the true source for some of the metabolites produced by sponges. γ-Proteobacteria was detected in the sponge isolate. An antileukemic marine natural product, sorbicillactone A was isolated from the salt water culture of the fungus Penicillium chrysogenum obtained from another Mediterranean specimen of Ircinia fasciculata. It possesses a unique bicyclic lactone structure, seemingly derived from sorbicillin. The compound exhibited promising activities in several mammalian and viral test systems, particularly in a highly selective cytostatic activity against murine leukemic lymphoblasts (L5178y) and also showed the ability to protect human T cells against the cytopathic effects of HIV-1. These properties qualify sorbicillactone A for future therapeutic human trials.

2.1.4.3. Family: Spongiidae

An antibacillus compound, which was chemically identified as the peptide antibiotic andrimid was detected in the extract of the sponge Hyatella sp. A bacterial isolate M22-1, belonging to the genus Vibrio was also isolated from the homogenate of the same sponge. The bacterium when cultured in marine agar also produced the same compound. This suggests that the origin of andrimid in the sponge is from the bacterium. Andrimid previously isolated from the cultures of an Enterobacter sp. which is an intracellular symbiont of the brown plant hopper Nilaparvata lugens and was found to exhibit potent activity against Xanthomonas campestris pv. oryzae. It has also been isolated from marine Pseudomonas fluorescens, which was active against methicillin-resistant Staphylococcus aureus. Due to the diversity of the microorganism producing this toxin, one can speculate that the production of this compound might be encoded by genes transferable on a plasmid. The culture broth extracts of the fungus, Myrothecium verrucaria 973023 which was separated from Spongia sp. of Hawaii, showed potent activity against murine lymphocytic leukemia L1210 and human colon tumor H116 cell lines in the soft agar-based bioassay system. Further studies indicated the presence of three new trichothecenes, viz. 3-hydroxyroridin E, 13′-acetyltrichoverrin B, miophytocen C and nine known related compounds such as roridin A, L, M, isororidin A, epiroridin E, verrucarin A, M, trichoverrin A and B in the extract. All the compounds except miophytocen C showed significant cytotoxicity against murine and human tumor cell lines.

2.1.4.4. Family: Thorectidae

A new antibiotic trisindole derivative, viz. trisindoline, has been characterized from a marine Vibrio sp., which was separated from the fresh marine okinawan sponge Hyrtios altum. Trisindoline was shown to exhibit potential antibiotic activity against Escherichia coli, Bacillus subtilis and Staphylococcus aureus. An antileukemic compound, asperazine was isolated from the saltwater culture of the fungus Aspergillus niger obtained from a caribbean Hyrtios sponge by Crews et al.. Asperazine is a member of a large family of diketopiperazine alkaloids. Asperazine displayed remarkable cytotoxicity and an interesting leukemia selectivity. Culture extract of another strain of Aspergillus niger from the sponge Hyrtios proteus (Dry Tortugas National Park, Florida) displayed broad chemodiversity and five compounds belonging to a wide range of biosynthetic classes were isolated. Among them, malformin C and asperazine displayed tumor and leukemia selective bioactivity. From the above findings, it can be deduced that Aspergillus niger associated with two different species of Hyrtios inhabiting different geographical locations is capable of producing asperazine. It also gives insight in to the adaptability of a particular microbial associate to a particular sponge genus. An epibiotic bacterial strain Pseudoalteromonas maricaloris KMM 636T, isolated from the Great Barrier Reef sponge Fascaplysinopsis reticulata was the source of two brominated chromopeptides such as bromoalterochromide A and bromoalterochromide A. They showed moderate cytotoxicity to the eggs of the sea urchin Strongylocentrotus intermedius.

2.1.5.1. Family: Spirastrellidae

A polyketide, 14,15-secocurvularin was isolated from the saltwater culture of an unidentified fungus obtained from an Indonesian encrusting sponge Spirastrella vagabunda. It was described as being mildly antibiotic against Bacillus subtilis when compared to tetracycline.

2.1.5.2. Family: Suberitidae

Suberites domuncula is yet another excellent source for the recovery of bacteria having bioactive potential. This sponge typically grows on snail shells and has a compact, smooth, waxy and colorful surface. Bacteria were isolated from the sponge surface as well as from the laboratory-developed primmorphs of Suberites domuncula collected from northern Adriatic Sea. Two bacteria isolated from the sponge surface were identified as α-Proteobacterium MBIC3368 by using 16S rDNA sequences. This bacterium has also been isolated from several other sponges (e.g., Rhopaloeides odorabile, Aplysina aerophoba) regardless of their taxonomic identity, geographic location or natural product profile. Another bacterial isolate from the sponge surface showed 98.8% species level similarity to Idiomarina loihiensis (Alteromonadaceae). The bacteria on primmorph represented unidentified novel species of Pseudomonas. Bioactive extracts of α-Proteobacterial strains from the sponge surface as well as Pseudomonas sp. associated with primmorph exhibited antiangiogenic, antimicrobial, hemolytic and cytotoxic properties. These bacterial extracts were strongly active against multidrug-resistant clinical strains of Staphylococcus aureus and Staphylococcus epidermidis, isolated from hospital patients. Extracts from Idiomarina species also showed hemolytic activity.

2.1.6.1. Family: Axinellidae

A cyclic depsipeptide, majusculamide C has been isolated from the metabolites of the sponge Ptilocaulis trachys collected at the Enewetak Atoll (Marshall Island, Pacific Ocean). It was originally isolated from the toxic blue-green alga Lyngbya majuscula obtained from the same site. Majusculamide C exhibited antifungal activity against pathogens of commercially important plants. This discovery proved that accumulation of cyanobacteria in sponges is diet derived. A symbiotic fungal strain Myrothecium sp. JS9 in the marine sponge Axinella sp. from South China Sea was found to be an efficient producer of most effective antifungal metabolites roridin A and D (macrocyclic trichothecenes). Biologically, this class of compounds was reported to possess antileukemic, antimalarial, antimicrobial, phytotoxic and cytotoxic properties. Structurally unique steroids, isocyclocitrinols A and 22-acetylisocyclocitrinol A were isolated from the extract of a saltwater culture of sponge derived fungus Penicillium citrinum, separated from the sponge Axinella sp., collected in Papua New Guinea. Both the steroid compounds exhibited weak antibacterial activity against Staphylococcus epidermidis and Enterococcus durans. The ethyl acetate extract of Penicillium sp., derived from the Mediterranean sponge Axinella verrucosa, yielded the known compound communesin B and its new congeners communesins C and D, and the known compounds oxaline, griseofulvin and dechlorogriseofulvin. Oxaline is an antiproliferative agent which inhibits microtubule protein/purified tubulin polymerization, resulting in arresting cell cycle at the M-phase. Griseofulvin is a widely used antifungal agent for the treatment of superficial dermatomycoses. In several bioassays performed on different leukemia cell lines, the communesins exhibited moderate antiproliferative activity. From a static culture of the fungal strain Aspergillus niger isolated from the Mediterranean sponge Axinella damicornis, eight secondary metabolites belonging to four entirely different structural classes were obtained. Among these, the new compound 3,3′-bicoumarin (bicoumanigrin A) showed moderate cytotoxicity against human cancer cell lines in vitro. Another compound, aspernigrin B displayed a strong neuroprotective effect by significantly reducing the increase of intracellular calcium concentration in rat cortical neurons stimulated with glutamic acid or quisqualic acid. A crude extract from a small-scale culture of the fungus Acremonium sp. 021172C cultured from an Axinella sp. collected from Milne Bay (Papua New Guinea) displayed potent cytotoxicity in a primary screening using leukemia and solid tumor murine and human cancer cell lines. This prompted the growth of a larger-scale culture of the fungus to facilitate the purification of potential therapeutic metabolites which resulted in four new related linear octapeptides, RHM1, 2, 3 and 4, and the known peptaibiotic efrapeptins E, F, G, new efrapeptins Eα and H, known cyclic N-methylated scytalidamides A and B. Efrapeptins displayed antibacterial activity and potent cytotoxicity against murine and human cancer cell lines. RHM1 and RHM2 showed only weak cytotoxicity against murine cancer cell lines but RHM1 exhibited antibacterial activity. These studies further confirm the potentiality of fungal metabolites from marine environment.

2.1.6.2. Family: Halichondriidae

The halichondrids form the most important members of demosponges. They are of particular interest because the composition of secondary metabolites is influenced by the presence of prokaryotic symbionts. Sponges of the genus Halichondria such as Halichondria okadai and Halichondria melanodocia provide good examples for the importance of microalgal association in the production of natural compounds recovered from these invertebrates. Both species of Halichondria contain the protein phosphatase inhibitor okadaic acid. It was first isolated from the sponge Halichondria okadai, but, later it was found out that a dinoflagellate Prorocentrum lima produced the inhibitor. Two unidentified bacteria of the genera Pseudomonas and Alteromonas have been isolated from Halichondria Okadai homogenates. The Pseudomonas sp. KK10206C produced a novel C50-carotenoid, okadaxanthine. It turned out to be a potent singlet oxygen quencher and a well known source of okadaic acid. Alteromonas sp. was responsible for the production of a well-known lactam alteramide A. The genus Alteromonas was found commonly associated with marine sponges that produce macrolactam and amide ester compounds with cytotoxic and antimicrobial properties. The tetracyclic alkaloid alteramide A exhibited cytotoxic activity against leukemia P-388, lymphoma L-1210 and epidermal carcinoma KB cells. A fungal strain, Trichoderma harzianum OUPS-N115, isolated from the Japanese specimen of Halichondria okadai yielded novel cytotoxic compounds such as trichodenone A, B and C. They exhibited significant cytotoxicity against leukemia P388 cell line. A Gram-bacterial strain Rubritalea squalenifasciens HOact23T obtained from Halichondria okadai yielded potent red pigmented antioxidants acyl glycol-carotenoic acids such as diapolycopenedioic acid xylosyl esters A, B and C. Another Halichondria species, Halichondria panacea, which occurs abundantly in the Adriatic Sea, North Sea and Baltic Sea, was colonized by bacteria in its mesohyl compartment. Moreover, different specimens of Halichondria panacea collected from all the three seas harboured bacteria of same genera and indicated the dominance of the genus Rhodobacter, suggesting the symbiotic relationship of these bacteria with the sponge. Evidence has been presented to support that growth of bacteria in Halichondria panacea is maintained by a lectin produced from eukaryotic host. The organic extracts prepared from the sponge samples displayed cytotoxicity against leukemia cells, which supports the possibility of toxic bacteria in the sponges. Bacteria synthesizing neuroactive compounds were also isolated from Halichondria panacea. Two such bacterial species were identified from this sponge which displayed the highest identity to Antarcticum vesiculatum and Psychroserpens burtonensis. An actinobacterium Microbacterium sp. isolated from the sponge Halichondria panacea (Adriatic coast, Croatia) produced four glycoglycerolipids and one diphosphatidylglycerol when grown on marine broth and artificial sea water. The glycoglycerolipid, 2 (1-O-acyl-3-[R-glucopyranosyl-(1–3)-(6-O-acyl-R-mannopyranosyl)]glycerol), showed positive results for antitumor activities in the initial studies. Novel cytotoxic compounds, designated as gymnastatins A-H, Q and R, cytotoxic ergastanoids such as gymnasterone A, B, C and D, novel class of steroid dankasterones A and B, and dankastatins A and B were isolated from an ascomycete fungal strain Gymnascella dankaliensis OUPS-N134, derived from the sponge Halichondria japonica. Gymnastatins A, B, C, F, G, Q and R, dankastatins A and B exhibited potent cytotoxicity and growth inhibition in a P388 lymphocytic leukemia test system in cell culture. Gymnastatin Q was equally active against breast and human cancer cell lines. Gymnasterones B, C and D, and dankasterone A showed significant cytotoxic activity in P388 lymphocytic leukemia test system in cell culture. Dankasterone A was also active against human cancer cell lines. Again from Halichondria Japonica, a fungal strain Phoma sp. Q60596 was obtained, which gave rise to the new antifungal antibiotic, YM-202204. It exhibited potent antifungal activities against Candida albicans, Cryptococcus neoformans and Aspergillus fumigatus. Novel antibiotics, YM-266183 and YM-266184, were found in the culture broth of Bacillus cereus QN03323, which was isolated from Halichondria japonica. They exhibited potent antibacterial activities against staphylococci and enterococci including multiple drug resistant strains, whereas they were inactive against Gram-bacteria. The antifungal macrolid halichondramide from another Halichondria sp. showed resemblance to the compound scytophycin B, which was extracted earlier from the cyanobacterium Scytonema pseudohofmanni, and therefore halichondramide is speculated to be of microbial origin. Halichondramide also showed in vitro antimalarial activity. The marine bacterial strain Bacillus pumilus AAS3 isolated from the Mediterranean sponge Acanthella acuta, produced a diglucosyl-glycerolipid, GGL11. Lipase catalyzed modification of this native substance led to the deacylated parent compound GG11. Antitumor promoting studies showed that the diglucosyl-glycerol GG11 strongly inhibited the growth of the tumor cell lines HM02 and Hep G2. Thus, it indicates the potential inhibitory activity of the compound with carbohydrate/glycerol backbone. Twenty nine marine bacterial strains were isolated from the sponge Hymeniacidon perlevis at Nanji Island (China Sea), and the antimicrobial screening showed that eight strains inhibited the growth of terrestrial microorganisms. Among them, the strain NJ6-3-1 with wide antimicrobial spectrum was identified as Pseudoalteromonas piscida based on its 16S rRNA sequence analysis. The major antimicrobial metabolite isolated from this bacterium was norhman. Another specimen of Hymeniacidon perlevis from the intertidal zone of Fujiazhuang coastline (China) was identified to be a good source of large amount of culturable and active epi/endophytic fungal strains. Of the various fungal isolates obtained from Hymeniacidon perlevis, the extracts of epiphytic fungus Fusarium oxysporum DLFP2008005 exhibited effective antibacterial and antifungal activities against Gram+ Staphylococcus epidermidis, Bacillus subtilis, Gram-Pseudomonas fluorescens, Pseudomonas aeruginosa and the yeast Candida albicans. Several terrestrial as well as marine Fusarium species have been reported to produce structurally diversified antimicrobial compounds. The potential of fungi of the genus Fusarium as producers of novel antibiotics is therefore quite evident.

2.1.7.1. Family: Callyspongiidae

An antimicrobial fungal metabolite known as acetyl Sumiki’s acid was isolated from a seawater-based fermentation of the fungal isolate Cladosporium herbarum, obtained from the marine sponge Callyspongia aerizusa in Indonesia. Both Sumiki’s acid and its acetyl derivative showed activity against Bacillus subtilis and Staphylococcus aureus at 5 μg/disc. The tropical sponge Callyspongia vaginalis from the Caribbean Sea, yielded a new tyrosine kinase inhibitor and the antimicrobial compound ulocladol together with the antifungal agent 1-hydroxy-6-methyl-8-(hydroxyl-methyl)xanthone. These compounds have been extracted from the culture of sponge-derived fungi Ulocladium botrylis 193A4.

2.1.7.2. Family: Chalinidae

The marine sponge genus Haliclona has been extensively examined, and at least 190 metabolites exhibiting anti-fouling, antimicrobial, antifungal, antimalarial and cytotoxic activities have been isolated. A fungal strain isolated from the sponge Haliclona valliculata collected from Elba, Italy and identified as Emericella variecolor showed a remarkable diversity of secondary metabolites. However, strains of the fungus Emericella variecolor have been the source of a variety of natural products. The culture of Emericella variecolor isolated from Haliclona valliculata proved to be chemically prolific. Among various compounds isolated, the novel anthraquinone, evariquinone revealed a strong antiproliferative activity against KB (ATCC CCL17, human cervix carcinoma) and NCI-H460 (NCI 503473, non-small cell lung cancer) cells. Associated with Haliclona simulans from the west coast of Ireland, 52 bacteria isolated belonged to the genera Pseudoalteromonas, Pseudomonas, Halomonas, Psychrobacter, Marinobacter, Sulfitobacter, Pseudovibrio, Salegentibacter, Bacillus, Cytophaga, Rhodococcus and Streptomyces. These strains were found to be rich sources of biological activities with over 50% exhibiting antimicrobial activities. Twelve Streptomyces and one Bacillus strain were found to produce substance active against drug-resistant pathogenic bacteria. PKS (polyketide synthase) and NRPS (nonribosomal peptide synthetase) genes found in Actinobacteria, Bacillus, Sulfitobacter and Pseudovibrio, suggest a high potential for secondary metabolite production by these organisms. Detection of wide spectrum antibiotic activities from Streptomyces isolates SM2 and SM4 is another evidence to support that culturable sponge microbiota is an important source of biologically active compounds. The saltwater culture of an unidentified fungus obtained from the sponge Haliclona sp. was found to produce several new hirsutane sesquiterpenes such as hirsutanols A–C and ent-gloeosteretriol. Hirsutanols are biosynthetically related to several compounds reported from the terrestrial fungus Coriolus consors. Hirsutanol A and ent-gloeosteretriol exhibited mild antibiotic activity against Bacillus subtilis. Potent bacterial strains from Haliclona sp. (Bandangan water, North Java Sea, Indonesia) exhibiting antibacterial activity against the pathogenic bacteria such as Vibrio parahaemolyticus, Aeromonas hydrophila and Staphylococcus aureus were identified using rep-PCR followed by the construction of dendrogram and subsequent DNA sequencing. The active strains showed closest similarity to Vibrio parahaemolyticus, Pseudovibrio denitrificans, Pseudoalteromonas sp., α-Proteobacterium and uncultured bacterium clone.

2.1.7.3. Family: Niphatidae

The fungus Curvularia lunata isolated from the marine sponge Niphates olemda from Indonesia yielded two antibacterial anthraquinones such as lunatin and cytoskyrin A. Both of them were found to be active against Staphylococcus aureus, Escherichia coli and Bacillus subtilis.

2.1.7.4. Family: Petrosiidae

Genus Petrosia has been recognized as a source of diverse metabolites. Petrosia ficiformis is a common Mediterranean sponge living in hard substrata between 5 and 45 m depth. Its colour mainly due to symbiotic cyanobacteria, ranges from violet to brown according to the illumination of environment. Petrosia ficiformis hosts a variety of heterotrophic bacteria, most of which live together with cyanobacteria within specialized cells called bacteriocytes. Antimicrobial activity in several epibiotic bacterial isolates from Petrosia ficiformis has been observed by Chelossi et al.. Two of these were identified as Rhodococcus sp. and Pseudomonas sp. by partial 16S rRNA gene sequencing. A strain of Penicillium brevicompactum derived from the specimen of Petrosia ficiformis provided two new cyclopentadepsipeptides, petrosifungins A and B along with the known fungal metabolites brevianamide A, mycophenolic acid (a well known immunosuppressive agent) and asperphenamate. Since cyclodepsipeptides constitute new class of potential drugs, petrosifungins A and B, may serve as lead compounds for more pharmacologically potent and toxicologically safe derivatives. A strain of Aspergillus insuetus obtained from the surface of Petrosia ficiformis yielded two new compounds, terretonins E and F. They are potent inhibitors of mammalian mitochondrial respiratory chain. One of the most potent antibacterial activities was detected in the crude extracts of a bacterial strain Micrococcus luteus R-1588-10, isolated from the surface of the sponge Xestospongia sp. collected from off Noumea (New Caledonia, southwest Pacific). Micrococcus luteus is an ubiquitous Gram+ bacteria. Two antimicrobial compounds such as 2,4,4′-trichloro-2′-hydroxydiphenylether (triclosan) and acyl-1-(acyl-6′-mannobiosyl)-3-glycerol (lutoside) have been isolated from Micrococcus luteus. Fungal isolates of Penicillium cf. montanense obtained from the sponge Xestospongia exigua from Bali Sea (Indonesia) has yielded three novel decalactone metabolites, xestodecalactones A, B, and C. Among these, xestodecalactone B showed antifungal activity against Candida albicans. An antibacterial compound, aspergillitine was also isolated from Xestospongia exigua in association with the fungus Aspergillus versicolor. It showed moderate antibacterial activity against Bacillus subtilis. An anti-infective alkaloid manzamine A was successfully obtained from the culture of the actinobacterium Micromonospora sp. harbouring the deep water Indonesian sponge Acanthostrongylophora sp.. Manzamine alkaloids were reported earlier from several unrelated and geographically separated sponges, which suggest the microbial origin for the biosynthesis of these compounds. Manzamine A was initially described as an antitumor agent against mouse leukemia cells and recently shown to possess antimalarial properties that inhibit in vivo the growth of the rodent malarial parasite Plasmodium berghei. Large scale culture of the sponge derived Micromonospora sp. has since been achieved in 20-litre fermentations, maintaining the manzamine production. The fungus Aspergillus versicolor, isolated from Petrosia sp. (Jeju Island, Korea) yielded three known polyketides such as decumbenones A, B and versiol, and the cytotoxic lipopeptide fellutamide C. The same polyketides have been also reported from soil associated fungus Penicillium decumbens. Decumbenone A is a good inhibitor of melanin.

2.1.8.1. Family: Neopeltidae

Lithistid sponges are renowned among marine organisms for their ability to produce a diverse array of biologically active metabolites, including novel peptides characterized by a high proportion of D and/or N-methylated amino acids. The similarity between lithistid peptides and those from microorganisms leads to the speculation that lithistid peptides might arise from symbiotic microbes. A Gram-strain, 1537–E7 was identified as new Pseudomonas species from the surface of the sponge Homophymia sp. collected from off Touho (New Caledonia). Among the five compounds isolated from this bacterium, compound 1 (2-undecyl-4-quinolone) was active against the malarial parasite Plasmodium falciparum and HIV-1. Compound 2 (2-undecen-1′-yl-4-quinolone) displayed mild toxicity and compound 4 (2-nonyl-4-hydroxyquinoline N-oxide) showed antimicrobial activity against Staphylococcus aureus as well as cytotoxicity.

2.1.8.2. Family: Theonellidae

The marine sponge Theonella swinhoei from Palau contains a cytotoxic polyketide, swinholide A and the bicyclic glycopeptide antifungal compound theopalauamide. Bacteria associated with this sponge include unicellular cyanobacteria, unicellular bacteria and filamentous bacteria. Swinholide A is likely to be a bacterial metabolite because this compound was associated with fractions from unicellular bacteria in Theonella swinhoei. A single morphotype of a filamentous bacterium was present in a separate fraction that contained the antifungal compound theopalauamide. Subsequent application of molecular approaches identified this filamentous bacterium as novel δ-Proteobacterium related to myxobacteria. According to 16S rDNA data, the filamentous strain is a previously unknown δ-Proteobacterium with close association to the myxococcales and designated as ‘Candidatus Entotheonella palauensis’. An antifungal glycopeptide known as theonegramide was previously isolated from Theonella swinhoei, collected from Philippines at a depth of 20 m. Interestingly, 16S sequences which showed 98% identity to that of the filamentous δ-Proteobacterium, Entotheonella palauensis were detected in Theonella swinhoei specimens containing the closely related metabolites theonegramide (from the Philippines) and theonellamide F (from Japan), while they were absent in sponges with different metabolites. Theopalauamide-type compounds therefore, seem to be chemical markers for symbiosis of Entotheonella palauensis in sponges. Discovery of onn genes encoding the biosynthesis of onnamide A in the microbial metagenome of the sponge Theonella swinhoei was made by Piel et al.. This polyketide exhibited extremely potent antitumor activities. This provides the first experimental proof for bacterial origin of marine sponge derived natural compounds.

2.1.9.1. Family: Acarnidae

Three novel cytotoxic polyketides, brocaenols A-C were produced by Penicillium brocae obtained from a tissue sample of the Fijian sponge Zyzzya sp. When tested against HCT-116 cell line, all three compounds showed cytotoxicity.

2.1.9.2. Family: Isodictyidae

An antibacterial compound known as cyclo-(l-proline-l-methionine) has been isolated from the culture broth of a symbiotic bacterium Pseudomonas aeruginosa, obtained from the Antarctic sponge Isodictya setifera. It showed antimicrobial activity against Bacillus subtilis, Staphylococcus aureus, and Micrococcus luteus.

2.1.9.3. Family: Raspailiidae

A fungal strain Coniothyrium sp. 193477, isolated from the sponge Ectyoplasia ferox from the waters around the Caribbean Islands of Dominica, yielded novel antimicrobial compounds such as (3S)-(3′,5′-dihydroxyphenyl)butan-2-one and 2-(1′(E)-propenyl)-octa-4(E),6(Z)-diene-1,2-diol together with known fungal metabolites such as (3R)-6-methoxymellein, (3R)-6-methoxy-7-chloromellein and cryptosporiopsinol. Among these, cryptosporiopsinol demonstrated significant antimicrobial activity. Potent cytotoxic compounds, epoxyphomalin A and B were discovered from Phoma sp., associated with Ectyoplasia ferox collected from the same region. The former one showed superior activity against various human tumor cell lines. Another fungus Spicellum roseum 193H15, derived from Ectyoplasia ferox was found to produce trichothecenes such as trichodermol and 8-deoxytrichothecin. They considerably inhibited the activity of LacCer synthase (role in oncogene expression and cell proliferation) in neuroblastoma cells. The fungus also yielded two cyclohexadepsipeptides, spicellamides A and B.

2.1.9.4. Family: Mycalidae

An actinobacterium strain Saccharopolyspora sp. nov. associated with the sponge Mycale plumose from Qingdao coast (China) showed cytotoxic activities against temperature sensitive mutant cell lines of mouse (tsFT210). This led to the isolation of two prodigiosins analogs-metacycloprodigiosin and undecylprodigiosin. Prodigiosins are a family of naturally occurring polypyrrole red pigments produced by a restricted group of microorganisms including Streptomyces and Serratia strains. They are known to exhibit a wide range of biological activities. Both the above mentioned prodigiosin analogs exhibited potent in vitro cytotoxic activity against cancer cell lines such as P388, HL60, A-549, BEL-7402 and SPCA4. The fungus Penicillium auratiogriseum was also isolated from the specimen of Mycale plumose taken from the same geographical area. A new cytotoxic compound (S)-2,4-dihydroxy-1-butyl-(4-hydroxy) benzoate and a known compound fructigenine A were obtained from the fungus. Both the compounds were tested for their antitumor activity and exhibited potent cytotoxic effects. Besides these, two new quinazoline alkaloids such as aurantiomides B and C showing moderate cytotoxic activities were isolated from another strain of Penicillium auratiogriseum associated with Mycale plumose from China. Exophilin A, a new antibacterial compound, was discovered in the culture of the fungus Exophiala pisciphila NI10102, that was isolated from a marine sponge Mycale adhaerens. Exophilin A showed antimicrobial activity against Gram+ bacteria.

2.1.9.5. Family: Myxillidae

A new antimicrobial fungal metabolite known as microsphaeropsisin together with the known compounds (R)-mellein, (3R,4S)-hydroxymellein, (3R,4R)-hydroxymellein and 4,8-dihydroxy-3,4-dihydro-2H-naphthalen-1-one were obtained from the fungal strain Microsphaeropsis sp. H5-50 associated with the marine sponge Myxilla incrustance, collected from Helgoland, Germany. Microsphaeropsin, an eremophilane derivative showed antifungal activity at the 50 μg level.

2.1.10.1. Family: Tetillidae

A chitinase exhibiting antifungal activity was isolated from marine Streptomyces sp. DA11 associated with south China sponge Craniella australiensis. Compared with chitinase derived from terrestrial organisms, marine chitinase with higher pH and salinity tolerance may contribute to special biotechnological applications. Therefore, novel marine chitinase could be of great importance.

2.1.11.1. Family: Aplysinellidae

Ten strains of marine actinobacteria belonging to the genus Salinospora were isolated from the Great Barrier Reef sponge Suberea clavata (formerly Pseudoceratina clavata). The Salinospora group, a relatively newly discovered group of actinobacteria, has great applied potential. The Salinospora strains previously isolated from marine sediments showed significant cancer cell cytotoxicities as well as antifungal and antibiotic activities. Significantly, Salinospora forms a potential new source of rifamycins and polyketide synthesis gene clusters specific to rifamycin synthesis. Salinospora isolate from Suberea clavata was found to produce compounds of the rifamycin class, including rifamycin B and rifamycin SV. Other culturable symbiotic bacterial communities isolated from Suberea clavata include α-, γ-Proteobacteria, Bacteriodetes and Firmicutes.

2.1.11.2. Family: Aplysinidae

Sponges of the Aplysinidae family are abundant in the subtropical and tropical waters of the Mediterranean Sea, Pacific and Atlantic Oceans. Aplysina sponges harbour large amounts of microorganisms with antimicrobial activities that are embedded within the mesohyl. The Mediterranean sponge Aplysina aerophoba is especially rich in bacteria. The amount of bacteria present in the sponge tissue matrix exceeds the microbial concentration of the seawater by two to three orders of magnitude. One of the studies conducted using FISH on Aplysina aerophoba and its sibling species Aplysina cavernicola showed that the bacterial profiles of both species was very similar. Up to 40% of the sponge biomass consisted of bacteria and cyanobacteria. A large fraction of the microbial community was specific to and permanently associated with the host sponge. The similarity of the bacterial communities in Aplysina aerophoba and Aplysina cavernicola corresponds to similarities in the natural product profiles of both sponges which are characterized by brominated alkaloids with cytotoxic activities and repellent properties against predators. Among the bacterial isolates obtained from these species those which showed antimicrobial activity were numerically the most abundant in the genus Pseudoalteromonas and the class α-Proteobacteria. A general pattern was observed in that Gram+ bacteria inhibited Gram+ strains while Gram-bacteria inhibited Gram− isolates. Antimicrobial activities were also found against clinical isolates, i.e., multi-drug resistant Staphylococcus aureus and Staphylococcus epidermidis strains isolated from hospital patients. The high recovery of strains with antimicrobial activity suggests that marine sponges represent an ecological niche which harbours largely uncharacterized microbial diversity and yet undiscovered metabolic potential. Antimicrobial activity of bacterial isolates from Aplysina aerophoba collected from the Mediterranean coast of France has been tested against a set of standard Gram+, Gram− and eukaryotic microorganisms. The results showed that Bacillus subtilis strains A184, A190 and A202 exhibited strong activity against the fungus Candida albicans. It is generally accepted that a combination of fungicidal and hemolytic activity in Bacillus is a valid indicator for the presence of lipopeptide from the iturin or surfactin class. For the Bacillus subtilis strains A184, A190 and A202, these features are consistent. The results of MALDI MS which was applied to study the production of secondary metabolites by Bacillus species showed that strain A184 produced surfactins, iturins and fengycins while strain A190 produced surfactin and strain A202 produced iturin. The highly versatile strain Bacillus subtilis A184 was highly active against the multidrug resistant pathogenic Staphylococcus aureus and Staphylococcus epidermidis. Another species, Bacillus pumilus A586 demostrated high activity against Staphylococcus aureus and produced plumilacidin containing β-hydroxy fatty acid (surfactin like compound). An undescribed fungus of the genus Microsphaeropsis, isolated from the Mediterranean specimen of Aplysina aerophoba, was shown to produce a Protein Kinase C inhibitor known as 10-Hydroxy-18-methoxylbetaenone. Since PKC plays an important role in neoplastic transformation, carcinogenesis and tumour cell invasion, those agents which inhibit the action of PKC are therapeutically very important.

2.1.11.3. Family: Pseudoceratinidae

Extract of Metarrhizium sp. 001103 from Pseudoceratina purpurea (Fiji), yielded six known N-methylated cyclic depsipeptides of the destruxin family. They include destruxins A, B, B2, desmethyl B, E and E2 chlorohydrin. Destruxins A, B2, desmethyl B and E chlorohydrin displayed selective inhibition of human tumor cell lines. E2 chlorohydrin showed cytotoxicity towards murine c38 cell line. E chlorohydrin was the most potent among the group.

2.2. Class: Calcarea

Order: Clathrinida

Family: Leucettidae

Nonribosomal cyclic peptide leucamide A was isolated from the sponge Leucetta microraphis, obtained from the Great Barrier Reef of Australia. The compound was found to inhibit the growth of three tumor cell lines (stomach carcinoma, liver carcinoma and liver carcinoma with mutated p53). Leucamide A closely resembles the compound albeit, which is found frequently in cyanobacteria. Scanning electromicrographs of Leucetta microraphis revealed the presence of microbial symbionts, including cyanobacteria in the tissue. The sponge-derived leucamide A might, therefore be produced by cyanobacteria associated with it and not by the invertebrate itself.

2.3. Unidentified sponges

A marine-derived strain of the fungus Emericella variecolor, obtained from a Venezuelan sponge, yielded new compounds along with a group of known metabolites. Some of the novel compounds such as varitriol and varixanthone exhibited potent pharmaceutical activities. Varitriol displayed increased potency towards selected renal, CNS and breast cancer cell lines, whereas varixanthone showed antimicrobial activity. Two novel antimycin antibiotics viz. urauchimycins A and B, were isolated from a fermentation broth of Streptomyces sp. Ni-80. The strain was isolated from an unidentified sponge. They are the first antimycin antibiotics which possess a branched side chain moiety. They exhibited inhibitory activity against morphological differentiation of Candida albicans. A strain of the fungus Microascus longirostris SF-73 from a marine sponge collected at Harrington Point (Otago Harbour, New Zealand) was found to produce secondary metabolites such as cathestatin A, B and C, which strongly inhibited cystein proteases. Since specific and selective protease inhibitors are potentially powerful tools in clinical therapy, these inhibitors could be used in inactivating the target proteases in the pathogenic processes of human diseases such as emphysema, arthritis, pancreatitis, thrombosis, high blood pressure, muscular dystrophy, cancers, AIDS and many others. Three antibacterial compounds were isolated from the fungus Aspergillus ostianus 01F313, derived from an unidentified sponge collected at Pohnpei (The federated state of Micronesia). They include 8-chloro-9-hydroxy-8,9-deoxyasperlactone, 9-chloro-8-hydroxy-8,9-deoxyasperlactone and 9-chloro-8-hydroxy-8,9-deoxyaspyrone. From the same strain, five cytotoxic compounds such as aspinorene, dihydroaspyrone, aspergillides A, B and C were also obtained when cultured in a brominated medium. They exhibited cytotoxicity against lymphocytic leukemia cells (L1210). Cultivation of the fungus Cryptosphaeria eunomia, obtained from an unidentified sponge at Pohnpei yielded the antimycobacterial compounds diaporthein A and B. These compounds have been previously isolated from the terrestrial fungus Diaporthe sp. BCC 6140.

3. Discussion

Sponge-microbial associations which synthesize clinically significant bioactive compounds have been discovered so far from geographically different regions such as Great Barrier Reef of Australia, South China Sea, Mediterranean Sea, Indonesia, Papua New Guinea, Indo-Pacific region etc. (Table 2). The review brings out the fact that members of the class Demospongiae are the richest producer of pharmacologically significant bioactive compounds in association with microbes. Out of 92 families under class Demospongiae, 26 familes have been identified to produce medicinally important bioactive compounds of microbial origin. They includes Ancorinidae, Chondrillidae, Darwinellidae, Dysideidae, Irciniidae, Spongiidae, Thorectidae, Spirastrellidae, Suberitidae, Axinellidae, Halichondriidae, Callyspongiidae, Chalinidae, Niphatidae, Petrosiidae, Neopeltidae, Theonellidae, Acarnidae, Raspailiidae, Isodictyidae, Mycalidae, Myxillidae, Tetillidae, Aplysinellidae, Aplysinidae and Pseudoceratinidae. The major orders which contribute maximum to the compound production are Halichondrida, Dictyoceratida and Poecilosclerida. Families which belong to the order Halichondrida such as Axinellidae and Halichondriidae are more influenced by microbes in the production of secondary metabolites. The microbial associates of halichondrid comprises broad spectrum of bacteria, actinobacteria, fungi and micro algae. Association of these microbes with different species of halichondrid sponges have been shown to be the real source of bioactive compounds exhibiting significant therapeutic effects. These compounds include alteramide, trichodenone A-C, gymnastatins A-C (antileukemic) YM-202204, YM-266183 and YM-266184 (antibiotics). Apart from these, species belonging to the families Chalinidae and Petrosiidae of the order Haplosclerida, Darwinellidae of the order Dendroceratida are also rich sources of bioactive compounds of microbial origin. Only one family from the class Calcarea has been identified as a source of pharmacologically significant bioactive compounds of microbial origin. There are no reports in the literature regarding isolation of microbial originated therapeutic compounds from the class Hexactinellida.

Some of the compounds produced by microbes in association with sponge orders such as Hadromerida, Haplosclerida and Verongida have not been characterized and therefore have not been included in the above figure.

The major groups of microorganisms recognized from this review as possible contributors of pharmacologically relevant secondary metabolites of sponges includes α, β, γ, δ- Proteobacteria, Firmicutes, Actinobacteria, Cyanobacteria and Fungi. Interestingly, the members of the fungal genus Aspergillus, which is ubiquitous in terrestrial, is also the principle source of bioactive compounds in marine sponges. Out of more than 680 fungal strains isolated worldwide from 16 sponge species, majority belong to the genera Aspergillus and Penicillium.The Fusarium genus is also considered as a potential candidate for the production of novel antibiotics. Even though most of the the sponge-microbial association is very specific for the production of a particular compound, a few compounds have also been isolated from free living and associated microbes in marine and terrestrial ecosystems. Tricyclic sesquiterpene coriolin B (anticancer) has been isolated from a marine fungus of the class Hyphomycetes in Jaspis. aff. johnstoni as well as from the terrestrial wood rotting basidiomycete Coriolus consors. Both the antimycobacterial compounds diaporthein A and B were isolated from the terrestrial fungus Diaporthe sp. and the marine fungus Cryptosphaeria eunomia associated with an unidentified sponge. Polyketides such as decumbenones A and B were earlier isolated from the soil fungus Penicillium decumbens and later from Aspergillus versicolor associated with Petrosia sp.. The antibacillus peptide antibiotic, associated with Petrosia sp.. The antibacillus peptide antibiotic, andrimid was isolated from Vibrio sp. M 22-1 associated with the sponge Hyatella sp. and also from a symbiotic Enterobacter sp. of the brown plant-hopper Nilaparvata lugens. Some sponges always harbour a particular genera or species of microorganism and consistently produce specific group of compounds. The association of the tropical marine shallow water sponge Lamellodysidea herbacea with cyanobacterium Oscillatoria spongeliae, is one such example which produces chlorinated diketopiperazines. Similarly, the symbiotic microbes of Dysidea sp. consistently synthesize brominated diphenyl ethers. Likewise, irrespective of the geographical region the antileukemic compound asperazine is produced by Aspergillus niger from two different Hyrtios species. Also, the antileukemic and antitumor compound roridin A is produced by Myrothecium sp. present in Spongia sp. of Hawaii and Axinella sp. of South China Sea.

Figures 2, 3 and 4 show the percentage distribution of clinically active compounds obtained from bacteria and fungi. Even though the number of bacterial isolates exhibiting clinical activities are more than fungi, many of the compounds produced by bacteria are not yet characterized. Figures 2 and 3 could be altered later once those compounds are characterized. Phylum Actinobacteria dominates in the production of therapeutic compounds followed by Proteobacteria. Bioactive potential of firmicutes and cyanobacteria is yet to be explored. Among fungi, Ascomycota is a predominant producer of bioactive molecules and Deuteromycota is also a potential group exhibiting bioactivity.

A wide range of chemical and functional diversity has been observed among bioactive compounds. Of the various chemical classes of compounds, polyketides, alkaloids, fatty acids, peptides and terpenes are the most abundant ones. Majority of them show antimicrobial, antitumor and anticancer properties. Bacterial and fungal associates in the order Dictyoceratida are found to synthesize antiangiogenic, anticancer, antiHIV, antitumor as well as antimicrobial compounds. Another noticeable fact is the discovery of an actinobacterial strain (Nocardiopsis dassonvillei MAD08) from the sponge Dendrilla nigra of the family Darwinellidae from southwest coast of India (Table 3). This particular strain was able to produce compounds exhibiting antimicrobial, antioxidant, hypocholesterolemic, nematicidal, antiandrogenic, hemolytic, anti-inflammatory and anticancer properties. Of the various compounds produced by this strain, hexadecanoic acid- methyl ester, n-hexadecanoic acid, hexadecanoic acid-ethyl ester, 9-octadecenoic acid (Z)-methyl ester, oleic acid and (E)-9-octadecenoic acid-ethyl ester have been shown to be multifunctional. Similarly the fungal strain Gymnascella dankaliensis OUPS-N134 from Halichondria japonica was very potent and produced 12 antileukemic compounds.

Some of the drugs available in the market, which were previously isolated from various terrestrial microbial genera were also detected in the marine counterparts associated with the sponges. A fungistatic drug, griseofulvin used for dermatophytoses has been isolated from various terrestrial and marine strains of Penicillium. This drug has also been reported from Penicillium symbiont of the Mediterranean sponge Axinella verrucosa. Similarly, a well known immunosuppressive and antibiotic drug, mycophenolic acid which was produced by various strains of Penicillium including Penicillium stoloniferum and Penicillium roqueforti has also been isolated from Penicillium brevicompactum associated with the sponge Petrosia ficiformis. Thus, the bioactive potential of the genus Penicillium either marine or terrestrial origin, free living or symbiotic makes it a worthy candidate for understanding the microbe-sponge association and harnessing the bioactive compounds.

4. Ecological and Cultural Aspects of Sponge Symbionts

To date, the primary target for marine bioprospecting has been tropical seas particularly coral reefs and other highly diverse ecosystems such as mangroves and seagrass because they host a high level of biodiversity and often face intense competition for space, leading to a chemical warfare among the sessile organisms. It was proven extremely difficult and in some cases impossible to provide sufficient quantity of these substances from invertebrates. The reason was due to the limited quantity of the compound, or still due to limited number of organisms producing the compound. Geographical, seasonal or sexual variations in the amount and nature of secondary metabolites could also be the other reasons for not consistently getting the required quantity of the compound. Marine invertebrates which are abundant in the Indo-Pacific regions, are rich in secondary metabolites and are becoming targets of continuing search for bioactive compounds. The China Sea has become an important source of marine natural compounds since 2001. Among metazoans, the phylum Porifera contains the taxa which produce the highest diversity of secondary metabolites.

With some exceptions, sponge-associated microbial communities appear to be relatively stable with time and space. With respect to temporal variability, the fluctuation of microbial communities in Aplysina aerophobha (an aquarium maintained specimen), Geodia barrette (Cultivated explant), temperate Australian sponges such as Callyspongia sp., Stylinos sp. and Cymbastela concentrica were detected to be low with no evidence of major seasonal changes. In contrast to these studies, the bacterial community abundant in the North Sea sponge Halichondria panacea was found to vary considerably over a 10 month period. Spatial variability could be ascribed to difference in microbiota within and among individuals which are separated by geographical barriers. Marked differences were evident between the microbial communities inhabiting the outer (cortex) and inner (endosome) tissue in the Mediterranean sponge Tethya aurantium. Contrary to this, Antarctic sponges such as Homaxinella balfourensis, Kirkpatrickia varialosa, Latrunculia apicalis, Mycale acerata and Sphaerotylus antarcticus collected from different sampling sites separated by 10 km were found to possess highly consistent bacterial communities. It highlights that site variability does not affect bacterial community composition in Antarctic sponges, but is highly consistent within a particular species. Another study by Taylor et al., showed that bacterial communities associated with temperate and tropical population of Cymbastela concentrica along the eastern Australian coast vary substantially.

Seasonal changes in the production of bioactive compounds by sponges are poorly understood. Seasonal fluctuations occurring in temperate seas impose significant alterations on the biology of the organism. Seasonal changes, both qualitative and quantitative, have been observed in bioactive compound production in the sponge Crambe crambe from Mediterranean Sea. More importantly, high intra individual variability has also been observed. High toxicity in the producer organism during autumn may be a defense mechanism to counter increased growth of competing animal species at the end of summer. A decrease in toxicity in the months preceding April could be due to the reproductive rhythm. Energy diversion towards reproduction may explain the decrease in toxic metabolite production. It was also found that non-polar fraction of the crude extract obtained from associated bacteria of the sponge Ircinia ramosa possessed strong antibacterial activity in summer. During winter season, activity was detected in the polar fraction and it was comparatively weaker than the observed activity in non-polar fraction during summer. This give insight in to the assumption that chemistry and production rate of metabolites from sponges or associated bacteria could be governed by environmental conditions. More studies are being done to show that microbes are the real source of many of the bioactive compounds in sponges. Future efforts may throw more light on seasonal effects of bioactive compound production by these associates.

The occurrence of important metabolites within sponge-associated bacteria opens up the possibility of providing a continuous supply of the biologically active compounds by laboratory cultivation of the producer. It would seem a logical step trying to isolate and cultivate putative bacterial producers outside invertebrate hosts in order to set up a sustainable and manageable source of pharmacologically active compounds. Even if microbial populations can be successfully separated from the hosts, the undefined metabolic factors of the host may render it difficult for the symbiont to grow ex hospite. Many bacterial inhabitants in sponges appear to be highly selective with regard to culture media and conditions which probably reflect their evolutionary adaptation to the conditions provided by the host. Attempts to culture the theopaulamide producing bacteria from the sponge Theonella swinhoei have failed so far. A notable exception is an anti-infective alkaloid manzamine A, which was successfully obtained from the culture of bacterium Micromonospora sp. of the deep-water Indonesian sponge Acanthostrongylophora sp.. Another possibility is to grow the entire sponge and its microbial community in self-contained aquaculture systems for the economic, sustainable supply of important metabolites. The advantage of the latter strategy compared with growth of sponges in the wild or in open-water mariculture system is the possibility of better control of environmental conditions such as temperature, light, food supply and possibly precursors of important bioactive metabolites. In addition, aquaculture of sponges may provide less perturbation of the bacterium-host association over growth of bacterial ‘producers’ strains in pure culture which could be very important for maintaining production of compounds of interest.

It is hypothesized that antagonism, polyketide synthase genes and PLA2 are the key functional precursors of secondary metabolite synthesis and/or host defense of marine sponges. The study of metabolite-related genes of microorganisms associated with sponges may give insight into the origin of sponge-derived natural products. Polyketides, comprising a large and structural diverse family of bioactive natural products are one of the most important classes of marine natural compounds. Polyketide synthase genes of host sponge and associated bacteria are predicted to be biosynthetic modules of polyketide analogues as well as phospholipases. The PKS gene-based molecular approach can be applied to efficient screening of strains of pharmaceutical value and prediction of related compounds. This strategy has been employed to discover the efficiency of polyketide production in Firmicutes especially Bacillus, Actinobacteria and Proteobacteria isolated from sponges of the South China Sea. Isolation and culture of symbiotic microorganisms as producers of secondary metabolites as well as transfer of symbiont biosynthetic genes into cultivable bacteria are subjects of ongoing research. Even if compounds or compound groups appear exclusive for a particular taxon, they are not necessarily homologous and derived from a common ancestor and therefore do not necessarily reflect a genealogical relationship. They might originate from different precursors and biochemical pathways. Rajdasa et al., highlighted the repetitive PCR method as a powerful tool in estimating the richness of secondary metabolite producers among colonizers of sponge Haliclona sp. and this approach may be useful in studying the diversity of other sponge-associated microorganisms.

5. Conclusions

Sponge-microbial associations are found to be very specific in the production of particular bioactive compounds. However, the mutual mechanism between host and the microbial associate, in compound production is not well understood. The easiest and best way for commercial production of these compounds are either by culturing the host and/or the associated microbe under controlled conditions. But, the ability of the symbiont to produce the compound consistently for several generation in culture media has to be tested and standardized. Moreover, there is a need for quantifying the role of sponge ecology in orchestrating the production of specific compounds. Metagenomic approaches are also being increasingly used for targeting putative genes encoding potential metabolites in uncultured microbial biota. These approaches would help in delineating the contribution of either the host or microbial associate or both partners in the production of metabolites. A few compounds have been found to be produced both in terrestrial and marine ecosystems by different groups of host-symbiont association. This suggests the possibility of horizontal gene transfer through evolution. Discovery of potent microbial associates producing therapeutic compounds has opened up a new era in marine pharmacology. Understanding the optimum ecological conditions which drives the sustainable production of bioactive compounds from sponges and their microbial associates would help in formulating various production strategies. Adopting different cultivation strategies and metagenomic approaches would be the need of the hour in discovering new genes, enzymes and natural products and in enhancing the commercial production of marine drugs.

References 204

  1. 1.

    Hentschel U Hopke J Horn M Friedrich AB Wagner M Hacker J Moore BS Molecular evidence for a uniform microbial community in sponges from different oceansAppl Environ Microbiol2002 6844314440

    Not in our library10.1128/aem.68.9.4431-4440.2002

  2. 2.

    Radjasa OK Sabdono A Junaidi Zocchi E Richness of secondary metabolite producing marine bacteria associated with sponge Haliclona spInt J Pharm2007 3275279

    Not in our library

  3. 3.

    Fusetani N Matsunaga S Bioactive sponge peptidesChem Rev1993 9317931806

    Not in our library

  4. 4.

    Lee YK Lee JH Lee HK Microbial symbiosis in marine spongesJ Microbiol2001 39254264

    Not in our library

  5. 5.

    Fieseler L Horn M Wagner M Hentschel U Discovery of the novel candidate Phylum “Poribacteria” in marine spongesAppl Environ Microbiol2004 7037243732

    Not in our library10.1128/aem.70.6.3724-3732.2004

  6. 6.

    Belarbi EH Gomez AC Chisti Y Camacho FG Grima EM Producing drugs from marine spongesBiotechnol Adv2003 21585598

    Not in our library10.1016/s0734-9750(03)00100-9

  7. 7.

    Thakur NL Müller WEG Biotechnological potential of marine spongesCurr Sci2004 8615061512

    Not in our library

  8. 8.

    Jensen PR Fenical W Strategies for the discovery of secondary metabolites from marine bacteria: ecological perspectivesAnnu Rev Microbiol1994 48559584

    Not in our library10.1146/annurev.mi.48.100194.003015

  9. 9.

    Bernan VS Greenstein M Maise WM Marine microorganisms as a source of new natural productsAdv Appl Microbiol1997 435789

    Not in our library10.1016/s0065-2164(08)70223-5

  10. 10.

    Haygood MG Schmidt EW Davidson SK Faulkner DJ Microbial symbionts of marine invertebrates: opportunities for microbial biotechnologyJ Molec Microbiol Biotechnol1999 13343

    Not in our library

  11. 11.

    Osinga R Armstrong E Burgess JG Hoffmann F Reitner J Schumann-Kindel G Sponge microbe associations and their importance for sponge bioprocess engineeringHydrobiologia2001 4615562

    Not in our library

  12. 12.

    Proksch P Edrada RA Ebel R Drugs from the seas: current status and microbiological imblicationsAppl Microbiol Biotechnol2002 59125134

    Not in our library10.1007/s00253-002-1006-8

  13. 13.

    Taylor MW Radax R Steger D Wagner M Sponge associated microorganisms: Evolution, ecology and biotechnological potentialMicrobiol Mol Biol Rev2007 71295347

    Not in our library10.1128/mmbr.00040-06

  14. 14.

    Wang G Diversity and biotechnological potential of the sponge-associated microbial consortiaJ Ind Microbiol Biotechnol2006 33545551

    Not in our library10.1007/s10295-006-0123-2

  15. 15.

    Thakur AN Thakur NL Indap MM Pandit RA Datar VV Müller WEG Antiangiogenic, antimicrobial and cytotoxic potential of sponge-associated bacteriaMar Biotechnol2005 7245252

    Not in our library10.1007/s10126-004-4085-y

  16. 16.

    Gunasekera AS Sfanos KS Harmody DK Pomponi SA McCarthy PJ Lopez JV An enhanced database of the microorganisms associated with deeper water marine invertebratesAppl Microbiol Biotechnol2004 66373376

    Not in our library10.1007/s00253-004-1763-7

  17. 17.

    Kobayashi J Ishibashi M Bioactive metabolites of symbiotic marine microorganismChem Rev1993 9317531769

    Not in our library

  18. 18.

    Ridley CP Faulkner DJ Haygood MG Investigation of Oscillatoria spongeliae dominated bacterial communities in four dictyoceratid spongesAppl Environ Microbiol2005 7173667375

    Not in our library10.1128/aem.71.11.7366-7375.2005

  19. 19.

    Alvarez B Crisp MD Driver F Hooper JNA Soest RWMV Phylogenetic relationships of the family Axinellidae (Porifera: Demospongiae) using morphological and molecular dataZool Scripta2000 29169198

    Not in our library

  20. 20.

    Bergmann W Burke DC Contributions to the study of marine products. XXXIX. The nucleosides of sponges. III. Spongothymidine and spongouridineJ Org Chem1955 2015011507

    Not in our library

  21. 21.

    Wang G Diversity and biotechnological potential of the sponge-associated microbial consortiaJ Ind Microbiol Biotechnol2006 33545551

    Not in our library10.1007/s10295-006-0123-2

  22. 22.

    Kennedy J Baker P Piper C Cotter PD Walsh M Mooij MJ Bourke MB Rea MC O’Connor PM Ross RP Hill C O’Gara F Marchesi JR Dobson ADW Isolation and analysis of bacteria with antimicrobial activities from the marine sponge Haliclona simulans collected from Irish watersMar Biotechnol2009 11384396

    Not in our library10.1007/s10126-008-9154-1

  23. 23.

    Li Z He L Miao X Cultivable bacterial community from South China Sea sponge as revealed by DGGE fingerprinting and 16S rDNA phylogenetic analysisCurr Microbiol2007 55465472

    Not in our library10.1007/s00284-007-9035-2

  24. 24.

    Head IM Saunders JR Pickup RW Microbial Evolution, Diversity, and Ecology: A Decade of Ribosomal RNA Analysis of Uncultivated MicroorganismsMicrob Ecol1998 35121

    Not in our library10.1007/s002489900056

  25. 25.

    Juretschko S Timmermann G Schmid M Schleifer K Pommerening-Röser A Koops H Wagner M Combined Molecular and Conventional Analyses of Nitrifying Bacterium Diversity in Activated Sludge: Nitrosococcus mobilis and Nitrospira-Like Bacteria as Dominant PopulationsAppl Environ Microbiol1998 6430423051

    Not in our library10.1128/aem.64.8.3042-3051.1998

  26. 26.

    Schmidt EW Obraztsova AY Davidson SK Faulkner DJ Haygood MG Identification of the antifungal peptide-containing symbiont of the marine sponge Theonella swinhoei as a novel δ-Proteobacterium Candidatus Entotheonella palauensisMar Biol2000 136969977

    Not in our library

  27. 27.

    Vacelet J Gallissian M Virus-like particles in cells of the sponge Virongia cavernicola (demospongiae, dictyoceratida) and accompanying tissue changesJ Invertebr Pathol1978 31246254

    Not in our library

  28. 28.

    Olson JB Mccarthy PJ Associated bacterial communities of two deep-water spongesAquat Microb Ecol2005 394755

    Not in our library

  29. 29.

    Hill M Hill A Lopez N Harriott O Sponge-specific bacterial symbionts in the Caribbean sponge, Chondrilla nucula (Demospongiae, Chondrosida)Mar Biol2006 14812211230

    Not in our library

  30. 30.

    Kasai H Katsuta A Sekiguchi H Matsuda S Adachi K Shindo K Yoon J Yokota A Shizuri Y Rubritalea squalenifaciens sp. nov., a squalene-producing marine bacterium belonging to subdivision 1 of the phylum ‘Verrucomicrobia’Int J Syst Evol Microbiol2007 5716301634

    Not in our library10.1099/ijs.0.65010-0

  31. 31.

    Enticknap JJ Kelly M Peraud O Hill RT Characterization of a culturable alphaproteobacterial symbiont common to many marine sponges and evidence for vertical transmission via sponge larvaeAppl Environ Microbiol2006 7237243732

    Not in our library10.1128/aem.72.5.3724-3732.2006

  32. 32.

    Thiel V Imhoff JF Phylogenetic identification of bacteria with antimicrobial activities isolated from Mediterranean spongesBiomol Eng2003 20421423

    Not in our library10.1016/s1389-0344(03)00069-8

  33. 33.

    Radjasa OK Martens T Grossart H Brinkhoff T Sabdono A Simmon M Antagonistic activity of a marine bacterium Pseudoalteromonas luteoviolacea TAB4.2 associated with coral Acropora spJ Biol Sci2007 7239246

    Not in our library

  34. 34.

    Zhang L An R Wang J Sun N Zhang S Hu J Kuai J Exploring novel bioactive compounds from marine microbesCurr Opin Microbiol2005 8276281

    Not in our library10.1016/j.mib.2005.04.008

  35. 35.

    Newman DJ Hill RT New drugs from marine microbes: the tide is turningJ Ind Microbiol Biotechnol2006 33539544

    Not in our library10.1007/s10295-006-0115-2

  36. 36.

    Perry NB Blunt JW Munro MHG Mycalamide A, an antiviral compound from a New Zealand sponge of the genus MycaleJ Am Chem Soc1988 11048504851

    Not in our library

  37. 37.

    Hood KA West LM Northcote PT Berridge MV Miller JH Induction of apoptosis by the marine sponge (Mycale) metabolites, mycalamide A and pateamineApoptosis2001 6207219

    Not in our library10.1023/a:1011340827558

  38. 38.

    Laport MS Santos OCS Muricy G Marine sponges: Potential sources of new antimicrobial drugsCurr Pharmaceut Biotechnol2009 1086105

    Not in our library10.2174/138920109787048625

  39. 39.

    Unson MD Holland ND Faulkner DJ A brominated secondary metabolite synthesized by the cyanobacterial symbiont of a marine sponge and accumulation of the crystalline metabolite in the sponge tissueMar Biol1994 119111

    Not in our library

  40. 40.

    Hentschel U Schmid M Wagner M Fieseler L Gernert C Hacker J Isolation and phylogenetic analyses of bacteria with antimicrobial activities from the Mediterranean sponges Aplysina aerophoba and Aplysina caverniculaFEMS Microbiol Ecol2001 35305312

    Not in our library10.1111/j.1574-6941.2001.tb00816.x

  41. 41.

    Zheng Z Zeng W Huang Y Yang Z Li J Cai H Su W Detection of antitumor and antimicrobial activities in marine organism associated actinomycetes isolated from the Taiwan Strait, ChinaFEMS Microbiol Lett2000 1888791

    Not in our library10.1111/j.1574-6968.2000.tb09173.x

  42. 42.

    Li Z Advances in marine microbial symbionts in the China Sea and related pharmaceutical metabolitesMar Drugs2009 7113129

    Not in our library10.3390/md7020113

  43. 43.

    Zhang Y Mu J Feng Y Kang Y Zhang J Gu P Wang Y Ma L Zhu Y Broad-spectrum antimicrobial epiphytic and endophytic fungi from marine organisms: Isolation, bioassay and taxonomyMar Drugs2009 797112

    Not in our library10.3390/md7020097

  44. 44.

    Biabani MAF Laatsch H Advances in chemical studies on low-molecular weight metabolites of marine fungiJ Prakt Chem1998 340589607

    Not in our library

  45. 45.

    Cheng X Varoglu M Abrell L Crews P Lobkovsky E Clardy J Chloriolins A-C, chlorinated sesquiterpenes produced by fungal cultures separated from a Jaspis marine spongeJ Org Chem1994 5963446348

    Not in our library

  46. 46.

    Sufrin JR Finckbeiner S Oliver CM Marine-Derived Metabolites of S-Adenosylmethionine as Templates for New Anti-InfectivesMar Drugs2009 7401434

    Not in our library10.3390/md7030401

  47. 47.

    Lang G Wiese J Schmaljohann R Imhoff JF New pentaenes from the sponge-derived marine fungus Penicillium rugulosum: structure determination and biosynthetic studiesTetrahedron2007 631184411849

    Not in our library

  48. 48.

    Blunt JW Copp BR Hu W Munro MHG Northcote PT Prinsep MR Marine natural productsNat Prod Rep2009 26170244

    Not in our library10.1039/b805113p

  49. 49.

    Selvin J Gandhimathi R Seghal Kiran G Shanmugha Priya S Ravji TR Hema TA Culturable heterotrophic bacteria from the marine sponge Dendrilla nigra: Isolation and phylogenetic diversity of actinobacteriaHelgol Mar Res2009 63239247

    Not in our library

  50. 50.

    Selvin J Exploring the antagonistic producer Streptomyces MSI051: Implications of polyketide synthase gene type II and a ubiquitous defense enzyme phospholipase A2 in the host sponge Dendrilla nigraCurr Microbiol2009 58459463

    Not in our library10.1007/s00284-008-9343-1

  51. 51.

    Selvin J Lipton AP Biopotentials of secondary metabolites isolated from marine spongesHydrobiologia2004 513231238

    Not in our library

  52. 52.

    Selvin J Joseph S Asha KRT Manjusha WA Sangeetha VS Jayaseema DM Antony MC Vinitha AJD Antibacterial potential of antagonistic Streptomyces sp. isolated from marine sponge Dendrilla nigraFEMS Microbiol Ecol2004 50117122

    Not in our library10.1016/j.femsec.2004.06.007

  53. 53.

    Selvin J Shanmughapriya S Gandhimathi R Kiran GS Ravji TR Natarajaseenivasan K Hema TA Optimization and production of novel antimicrobial agents from sponge associated marine actinomycetes Nocardiopsis dassonvillei MAD08Appl Microbiol Biotechnol2009 83435445

    Not in our library10.1007/s00253-009-1878-y

  54. 54.

    Hinde R Pironet F Borowitzka MA Isolation of Oscillatoria spongeliae, the filamentous cyanobacterial symbiont of the marine sponge Dysidea herbaceaMar Biol1994 11999104

    Not in our library

  55. 55.

    Arillo A Bavestrello G Burlando B Sara M Metabolic integration between symbiotic cyanobacteria and sponges: a possible mechanismMar Biol1993 117159162

    Not in our library

  56. 56.

    Unson MD Faulkner DJ Cyanobacterial symbiont biosynthesis of chlorinated metabolites from Dysidea herbacea (Porifera)Cell Mol Life Sci1993 49349353

    Not in our library

  57. 57.

    Flowers AE Garson MJ Webb RI Dumdei EJ Charan RD Cellular origin of chlorinated diketopiperazines in the dictyoceratid sponge Dysidea herbacea (Keller)Cell Tissue Res1998 292597607

    Not in our library10.1007/s004410051089

  58. 58.

    Besada P Mamedova L Thomas CJ Costanzi S Jacobson KA Design and synthesis of new bicyclic diketopiperazines as scaffolds for receptor probes of structurally diverse functionalityOrg Biomol Chem2005 320162025

    Not in our library10.1039/b416349d

  59. 59.

    Elyakov GB Kuznetsova T Mikhailov VV Maltsev II Voinov VG Fedoreyev SA 1991 Brominated diphenyl ethers from a marine bacterium associated with the sponge Dysidea spCell Mol Life Sci1991 47632633

    Not in our library

  60. 60.

    Scheuermayer M Pimentel-Elardo S Fieseler L Grozdanov L Hentschel U Proksch P Müller WEG Microorganisms of sponges: Phylogenetic diversity and biotechnological potentialFrontiers in Marine BiotechnologyHorizon BioscienceNorfolk, UK2006 289312

    Not in our library

  61. 61.

    Thakur NL Müller WEG Sponge-bacteria association: A useful model to explore symbiosis in marine invertebratesSymbiosis2005 39109116

    Not in our library

  62. 62.

    Müller WEG Thakur NL Ushijima H Thakur AN Krasko A Pennec G Indap MM Perovic-Ottstadt S Schröder HC Lang G Bringmann G Matrix-mediated canal formation in primmorphs from the sponge Suberites domuncula involves the expression of a CD36 receptor-ligand systemJ Cell Sci2004 11725792590

    Not in our library10.1242/jcs.01083

  63. 63.

    Mohamed NM Rao V Hamann MT Kelly M Hill RT Monitoring bacterial diversity of the marine sponge Ircinia strobilina upon transfer to aquacultureAppl Environ Microbiol2008 7441334143

    Not in our library10.1128/aem.00454-08

  64. 64.

    Bringmann G Lang G Muhlbacher J Schaumann K Steffens S Rytik PG Hentschel U Morschhauser J Müller WEG Sorbicillactone A: A structurally unprecedented bioactive novel-type alkaloid from a sponge-derived fungusProg Mol Subcell Biol2003 37231253

    Not in our library10.1007/978-3-642-55519-0_9

  65. 65.

    Bringmann G Gulder TAM Lang G Schmitt S Stöhr R Wiese J Nagel K Imhoff JF Large–scale biotechnological production of the antileukemic marine natural product sorbicillactone AMar Drugs2007 52330

    Not in our library10.3390/md502023

  66. 66.

    Oclarit JM Okada H Ohta S Kaminura K Yamaoka Y Iizuka T Miyashiro S Ikegami S Anti-bacillus substance in the marine sponge, Hyatella species, produced by an associated Vibrio species bacteriumMicrobios1994 78716

    Not in our library

  67. 67.

    Fredenhagen A Tamura SY Kenny PTM Komura H Naya Y Nakanishi K Nishiyama K Sugiura M Kita H Andrimid, a new peptide antibiotic produced by an intracellular bacterial symbiont isolated from a brown planthopperJ Am Chem Soc1987 10944094411

    Not in our library

  68. 68.

    Needham J Kelly MT Ishige M Andersen RJ Andrimid and moiramides A-C, metabolites produced in culture by a marine isolate of the bacterium Pseudomonas fluorescens: Structure elucidation and biosynthesisJ Org Chem1994 5920582063

    Not in our library

  69. 69.

    Amagata T Rath C Rigot JF Tarlov N Tenney K Valeriote FA Crews P Structures and cytotoxic properties of trichoverroids and their macrolide analogues produced by saltwater culture of Myrothecium verrucariaJ Med Chem2003 4643424350

    Not in our library10.1021/jm030090t

  70. 70.

    Kobayashi M Kitagawa I Bioactive substances isolated from marine sponge, a miniature conglomerate of various organismsPure Appl Chem1994 66819826

    Not in our library

  71. 71.

    Kobayashi M Aoki S Gato K Matsunami K Kurosu M Kitagawa I Marine natural products. XXXIV. Trisindoline, a new antibiotic indole trimer, produced by a bacterium of Vibrio sp. separated from the marine sponge Hyrtios altumChem Pharm Bull1994 4224492451

    Not in our library10.1248/cpb.42.2449

  72. 72.

    Braekman J Daloze D Chemical and biological aspects of sponge secondary metabolitesPhytochem Rev2004 3275283

    Not in our library

  73. 73.

    Varoglu M Corbett TH Valeriote FA Crews P Asperazine, a selective cytotoxic alkaloid from a sponge-derived culture of Aspergillus nigerJ Org Chem1997 6270787079

    Not in our library10.1021/jo970568z

  74. 74.

    Govek SP Overman LE Total synthesis of asperazineJ Am Chem Soc2001 12394689469

    Not in our library10.1016/j.tet.2007.05.127

  75. 75.

    Varoglu M Crews P Biosynthetically diverse compounds from a saltwater culture of sponge derived Aspergillus nigerJ Nat Prod2000 634143

    Not in our library10.1021/np9902892

  76. 76.

    Speitling M Smetanina OF Kuznetsova TA Laatsch H Bromoalterochromides A and A′, unprecedented chromopeptides from a marine Pseudoalteromonas maricaloris strain KMM 636TJ Antibiot2007 603642

    Not in our library10.1038/ja.2007.5

  77. 77.

    Abrell LM Borgeson B Crews P A new polyketide, secocurvularin, from the salt water culture of a sponge derived fungusTetrahedon Lett1996 3789838984

    Not in our library

  78. 78.

    Bugni TS Ireland CM Marine derived fungi: a chemically and biologically diverse group of microorganismsNat Prod Rep2004 21143163

    Not in our library10.1039/b301926h

  79. 79.

    Thakur NL Hentschel U Krasko A Pabel CT ANR AC Müller WEG Antibacterial activity of the sponge Suberites domuncula and its primmorphs: potential basis for epibacterial chemical defenseAquat Microb Ecol2003 317783

    Not in our library

  80. 80.

    Webster NS Hill RT The culturable microbial community of the Great Barrier Reef sponge Rhopaloeides odorabile is dominated by an α-ProteobacteriumMar Biol2001 138843851

    Not in our library

  81. 81.

    Williams DE Burgoyne DL Rettig SJ Andersen RJ Fathi-Afshar ZR Allen TM The isolation of Majusculamide C from the sponge Ptilocaulis trachys collected in Enewetak and determination of the absolute configuration of the 2-methyl-3-aminopentanoic acid residueJ Nat Prod1993 56545551

    Not in our library

  82. 82.

    Dunlap WC Battershill CN Liptrot CH Cobb RE Bourne DG Jaspars M Long PF Newman DJ Biomedicinals from the phytosymbionts of marine invertebrates: A molecular approachMethods2007 42358376

    Not in our library10.1016/j.ymeth.2007.03.001

  83. 83.

    Xie LW Jiang SM Zhu HHl Sun W Ouyang YC Dai SK Li X Potential inhibitors against Sclerotinia sclerotiorum, produced by the fungus Myrothecium sp. associated with the marine sponge Axinella spEur J Plant Pathol2008 122571578

    Not in our library

  84. 84.

    Amagata T Amagata A Tenney K Valeriote FA Lobkovsky E Clardy J Crews P Unusual C25 steroids produced by a sponge-derived Penicillium citrinumOrg Lett2003 543934396

    Not in our library10.1021/ol0356800

  85. 85.

    Koizumi Y Arai M Tomoda H Omura S Oxaline, a fungal alkaloid, arrests the cell cycle in M phase by inhibition of tubulin polymerizationBiochim Biophys Acta2004 16934755

    Not in our library10.1016/j.bbamcr.2004.04.013

  86. 86.

    Kolachana P Smith MT Induction of kinetochore-positive micronuclei in human lymphocytes by the anti-fungal drug griseofulvinMutat Res1994 322151159

    Not in our library10.1016/0165-1218(94)90001-9

  87. 87.

    Jadulco R Edrada RA Ebel R Berg A Schaumann K Wray V Steube K Proksch P New communesin derivatives from the fungus Penicillium sp. derived from the Mediterranean sponge Axinella verrucosaJ Nat Prod2004 677881

    Not in our library10.1021/np030271y

  88. 88.

    Hiort J Maksimenka K Reichert M Perovic-Ottstadt S Lin WH Wray V Steube K Schaumann K Weber H Proksch P Ebel R Müller WEG Bringmann G New natural products from the sponge-derived fungus Aspergillus nigerJ Nat Prod2004 6715321543

    Not in our library10.1021/np030551d

  89. 89.

    Boot CM Tenney K Valeriote FA Crews P Highly N-methylated linear peptides produced by an atypical sponge-derived Acremonium spJ Nat Prod2006 698392

    Not in our library10.1021/np0503653

  90. 90.

    Boot CM Amagata T Tenney K Compton JE Pietraszkiewicz H Valeriote FA Crews P Four classes of structurally unusual peptides from two marine-derived fungi: structures and bioactivitiesTetrahedon2007 6399039914

    Not in our library10.1016/j.tet.2007.06.034

  91. 91.

    Erpenbeck D Breeuwer JAJ van der Velde HC van Soest RWM Unravelling host and symbiont phylogenies of halichondrid sponges (Demospongiae, Porifera) using mitochondrial markerMar Biol2002 141377386

    Not in our library

  92. 92.

    Miki W Otaki N Yokoyama A Izumida H Shimidzu N Okadaxanthin, a novel C50-carotenoid from a bacterium Pseudomonas sp. KK10206C associated with a marine sponge Halichondria okadaiExperientia1994 50684686

    Not in our library

  93. 93.

    Kelecom A Secondary metabolites from marine microorganismsAn Acad Bras Cienc2002 74151170

    Not in our library10.1590/s0001-37652002000100012

  94. 94.

    Shigemori H Bae MA Yazawa K Sasaki T Kobayashi J Alteramide A, a new tetracyclic alkaloid from a bacterium Alteromonas sp. associated with the marine sponge Halichondria okadaiJ Org Chem1992 5743174320

    Not in our library

  95. 95.

    Bhalla TC Sharma M Sharma NN Satyanarayana T Chand S Microbial production of flavours and fragrances; fats and oils; dyes; bioplastics (PHAS); polysaccharides; pharmacologically active substances from marine microbes; anticancer agents and microbial transformationApplied MicrobiologyNational Science Digital Library NISCAIRNew Delhi, India2008 7134

    Not in our library

  96. 96.

    Amagata T Usami Y Minoura K Ito T Numata A Cytotoxic substances produced by a fungal strain from a sponge: physico-chemical properties and structuresJ Antibiot1998 513340

    Not in our library10.7164/antibiotics.51.33

  97. 97.

    Usami Y Ikura T Amagata T Numata A First total syntheses and configurational assignments of cytotoxic trichodenones A–CTetrahedron-Asymmetry2000 1137113725

    Not in our library

  98. 98.

    Shindo K Asagi E Sano A Hotta E Minemura N Mikami K Tamesada E Misawa N Maoka T Diapolycopenedioic Acid Xylosyl Esters A, B, and C, Novel Antioxidative Glyco-C30-carotenoic Acids Produced by a New Marine Bacterium Rubritalea squalenifaciensJ Antibiot2008 61185191

    Not in our library10.1038/ja.2008.28

  99. 99.

    Althoff K Schutt C Steffen R Batel R Müller WEG Evidence for a symbiosis between bacteria of the genus Rhodobacter and the marine sponge Halichondria panicea: Harbor also for putatively toxic bacteria?Mar Biol1998 130529536

    Not in our library

  100. 100.

    Perovic S Wichels A Schutt C Gerdts G Pahler S Steffen R Müller WEG Neuroactive compounds produced by bacteria from the marine sponge Halichondria panicea: activation of the neuronal NMDA receptorEnviron Toxicol Pharmacol1998 6125133

    Not in our library10.1016/s1382-6689(98)00028-3

  101. 101.

    Wicke C Hners M Wray V Nimtz M Bilitewski U Lang S Production and structure elucidation of glycoglycerolipids from a marine sponge associated Microbacterium speciesJ Nat Prod2000 63621626

    Not in our library10.1021/np990313b

  102. 102.

    Numata A Amagata T Minoura K lto T Gymnastatins, novel cytotoxic metabolites produced by a fungal strain from a spongeTetrahedon Lett1997 3856755678

    Not in our library

  103. 103.

    Amagata T Doi M Ohta T Minoura K Numata A Absolute stereostructures of novel cytotoxic metabolites, gymnastatins A–E, from a Gymnascella species separated from a Halichondria spongeJ Chem Soc Perkin Trans 11998 135853599

    Not in our library

  104. 104.

    Amagata T Doi M Tohgo M Minoura K Numata A Dankasterone, a new class of cytotoxic steroid produced by a Gymnascella species from a marine spongeChem Commun1999 13211322

    Not in our library

  105. 105.

    Mayer AMS Marine Pharmacology in 1998: Antitumor and Cytotoxic CompoundsPharmacologist1999 41159164

    Not in our library

  106. 106.

    Amagata T Minoura K Numata A 2006. Gymnastatins F-H, Cytostatic Metabolites from the Sponge-Derived Fungus Gymnascella dankaliensisJ Nat Prod2006 6913841388

    Not in our library10.1021/np0600189

  107. 107.

    Amagata T Tanaka M Yamada T Minoura K Numata A Gymnastatins and Dankastatins, Growth Inhibitory Metabolites of a Gymnascella Species from a Halichondria SpongeJ Nat Prod2008 71340345

    Not in our library10.1021/np070529a

  108. 108.

    Amagata T Tanaka M Yamada T Doi M Minoura K Ohishi H Yamori T Numata A Variation in Cytostatic Constituents of a Sponge-Derived Gymnascella dankaliensis by Manipulating the Carbon SourceJ Nat Prod2007 7017311740

    Not in our library10.1021/np070165m

  109. 109.

    Amagata T Minoura K Numata A Gymnasterones, novel cytotoxic metabolites produced by a fungal strain from a spongeTetrahedron Lett1998 3937733774

    Not in our library

  110. 110.

    Nagai K Kamigiri K Matsumoto H Kawano Y Yamaoka M Shimoi H Watanabe M Suzuki K YM-202204, a new antifungal antibiotic produced by marine fungus Phoma spJ Antibiot2002 5510361041

    Not in our library10.7164/antibiotics.55.1036

  111. 111.

    Nagai K Kamigiri K Arao N Suzumura K Kawano Y Yamaoka M Zhang H Watanabe M Suzuki K YM-266183 and YM-266184, novel thiopeptide antibiotics produced by Bacillus cereus isolated from a marine sponge. I. Taxonomy, fermentation, isolation, physico-chemical properties and biological propertiesJ Antibiot2003 56123128

    Not in our library10.7164/antibiotics.56.123

  112. 112.

    Suzumura K Yokoi T Funatsu M Nagai K Tanaka K Zhang H Suzuki K YM-266183 and YM-266184, novel thiopeptide antibiotics produced by Bacillus cereus isolated from a marine sponge II. Structure elucidationJ Antibiot2003 56129134

    Not in our library10.7164/antibiotics.56.129

  113. 113.

    Laatsch H Proksch P Müller WEG Marine bacterial metaboliteFrontiers in Marine BiotechnologyHorizon BioscienceNorfolk, UK2006 225288

    Not in our library

  114. 114.

    Hildebrand M Waggoner LE Lim GE Sharp KH Ridley CP Haygood MG Approaches to identify, clone, and express symbiont bioactive metabolite genesNat Prod Rep2003 21122142

    Not in our library10.1039/b302336m

  115. 115.

    El Sayed KA Dunbar DC Perry TL Wilkins SP Hamann MT Marine natural products as prototype insecticidal agentsJ Agric Food Chem1997 4527352739

    Not in our library10.1021/jf0207880

  116. 116.

    Ramm W Schatton W Wagner-Dobler I Wray V Nimtz M Tokuda H Enjyo F Nishino H Beil W Heckmann R Lurtz V Lang S Diglucosyl-glycerolipids from the marine sponge-associated Bacillus pumilus strain AAS3: their production, enzymatic modification and propertiesAppl Microbiol Biotechnol2004 64497504

    Not in our library10.1007/s00253-003-1471-8

  117. 117.

    Zheng L Chen H Han X Line W Yan X Antimicrobial screening and active compound isolation from marine bacterium NJ6-3-1 associated with the sponge Hymeniacidon perleveWorld J Microbiol Biotechnol2005 21201206

    Not in our library

  118. 118.

    Jadulco R Proksch P Wray V Sudarsono Berg A Grafe U New macrolides and furan carboxylic acid derivative from the sponge derived fungus Cladosporium herbarumJ Nat Prod2001 64527530

    Not in our library10.1021/np000401s

  119. 119.

    Höller U König GM Wright AD A new tyrosine kinase inhibitor from a marine isolate of Ulocladium botrytis and new metabolites from the marine fungi Asteromyces cruciatus and Varicosporina ramulosaEur J Org Chem1999 199929492955

    Not in our library

  120. 120.

    König GM Kehraus S Seibert SF Abdel-Lateff A Müller D Natural products from marine organisms and their associated microbesChem Bio Chem2005 7229238

    Not in our library10.1002/cbic.200500087

  121. 121.

    Yu S Deng Z Proksch P Lin W Oculatol, oculatolide and A-nor sterols from the sponge Haliclona oculataJ Nat Prod2006 6913301334

    Not in our library10.1021/np0600494

  122. 122.

    Bringmann G Lang G Steffens S Gunther E Schaumann K Evariquinone, isoemericellin, and stromemycin from a sponge derived strain of the fungus Emericella variecolorPhytochemistry2003 63437443

    Not in our library10.1016/s0031-9422(03)00189-4

  123. 123.

    Wang G Abrell LM Avelar A Borgeson BM Crews P New hirsutane based sesquiterpenes from salt water cultures of a marine sponge derived fungus and the terrestrial fungus Coriolus consorsTetrahedron1998 5473357342

    Not in our library

  124. 124.

    Bhadury P Mohammad BT Wright PC The current status of natural products from marine fungi and their potential as anti-infective agentsJ Ind Microbiol Biotechnol2006 33325337

    Not in our library10.1007/s10295-005-0070-3

  125. 125.

    Jadulco R Brauers G Edrada RU Ebel R Wray V Sudarsono Proksch P New metabolites from sponge derived fungi Curvularia lunata and Cladosporium herbarumJ Nat Prod2002 65730733

    Not in our library10.1021/np010390i

  126. 126.

    Kim JS Im KS Jung JH New bioactive polyacetylenes from the marine sponge Petrosia spTetrahedron1998 5431513158

    Not in our library

  127. 127.

    Lim YJ Park HS Im KS Lee CO Hong J Lee M Kim D Jung JH Additional cytotoxic polyacetylenes from the marine sponge Petrosia spJ Nat Prod2001 644653

    Not in our library10.1021/np000252d

  128. 128.

    Vacelet J Donadey C Electron microscope study of the association between some sponges and bacteriaJ Exp Mar Bio Ecol1977 30301314

    Not in our library

  129. 129.

    Chelossi E Milanese M Milano A Pronzato R Riccardi G Characterisation and antimicrobial activity of epibiotic bacteria from Petrosia ficiformis (Porifera, Demospongiae)J Exp Mar Biol Ecol2004 3092133

    Not in our library

  130. 130.

    Bringmann G Lang G Steffens S Schaumann K Petrosifungins A and B, novel cyclodepsipeptides from a sponge-derived strain of Penicillium brevicompactumJ Nat Prod2004 67311315

    Not in our library10.1021/np034015x

  131. 131.

    Lemmens-Gruber R Kamyar MR Dornetshuber R Cyclodepsipeptides - Potential drugs and lead compounds in the drug development processCurr Med Chem2009 1611221137

    Not in our library10.2174/092986709787581761

  132. 132.

    López-Gresa MP Cabedo N González-Mas MC Ciavatta MA Avila C Primo J Terretonins E and F, Inhibitors of the Mitochondrial Respiratory Chain from the Marine-Derived Fungus Aspergillus insuetusJ Nat Prod2009 7213481351

    Not in our library10.1021/np900085n

  133. 133.

    Bultel-Poncé V Debitus C Berge J Cerceau C Guyot M Metabolites from the sponge-associated bacterium Micrococcus luteusJ Mar Biotechnol1998 6233236

    Not in our library

  134. 134.

    Edrada RA Heubes M Brauers G Wray V Berg A Grafe U Wohlfarth M Muhlbacher J Schaumann K Sudarsono S Bringmann G Proksch P Online analysis of xestodecalactones A-C, novel bioactive metabolites from the fungus Penicillium cf. montanense and their subsequent isolation from the sponge Xestospongia exiguaJ Nat Prod2002 6515981604

    Not in our library10.1021/np020085c

  135. 135.

    Lin W Brauers G Ebel R Wray V Berg A Sudarsono Proksch P Novel chromone derivatives from the fungus Aspergillus versicolor isolated from the marine sponge Xestospongia exiguaJ Nat Prod2002 665761

    Not in our library10.1021/np020196b

  136. 136.

    El Sayed KA Kelly M Kara UAK Ang KKH Katsuyama T Dumbar DC Khan AA Hamann MT New manzamine alkaloids with potent activity against infectious diseasesJ Am Chem Soc2001 12318041808

    Not in our library10.1021/ja002073o

  137. 137.

    Sakai R Higa T Jefford CW Bernardinelli G Manzamine A, a novel antitumor alkaloid from a spongeJ Am Chem Soc1986 10864046405

    Not in our library

  138. 138.

    Ang KKH Holmes MJ Higa T Hamann MT Kara UAK In vivo antimalarial activity of the beta-carboline alkaloid manzamine AAntimicrob Agents Chemother2000 4416451649

    Not in our library10.1128/aac.44.6.1645-1649.2000

  139. 139.

    Lee YM Mansoor TA Hong J Lee C-O Bae KS Jung JH Polyketides from a Sponge-Derived Fungus, Aspergillus versicolorNat Prod Sci2007 139096

    Not in our library

  140. 140.

    Lee YM Dang HT Hong J Lee C-O Bae KS Kim DK Jung JH A Cytotoxic Lipopeptide from the Sponge-Derived Fungus Aspergillus versicolorBull Korean Chem Soc2010 31205208

    Not in our library

  141. 141.

    Fujii Y Asahara M Ichinoe M Nakajima H Fungal melanin inhibitor and related compounds from Penicillium decumbensPhytochemistry2002 60703708

    Not in our library10.1016/s0031-9422(02)00196-6

  142. 142.

    Bultel-Poncé V Berge J Debitus C Nicolas J Guyot M Metabolites from the sponge associated bacterium Pseudomonas speciesMar Biotechnol1999 1384390

    Not in our library10.1007/pl00011792

  143. 143.

    Capon RJ Ford J Lacey E Gill JH Heiland K Friedel T Phoriospongin A and B: Two new nematocidal depsipeptides from the Australian marine sponges Phoriospongia sp. and Callyspongia bilamellataJ Nat Prod2002 65358363

    Not in our library10.1021/np010329d

  144. 144.

    Bewley CA Faulkner DJ Lithistid sponges: Star performers or hosts to the starsAngew Chem Int Ed1998 3721622178

    Not in our library10.1002/(sici)1521-3773(19980904)37:16<2162::aid-anie2162>3.0.co;2-2

  145. 145.

    Bewley CA Holland ND Faulkner DJ Two classes of metabolites from Theonella swinhoei are localized in distinct populations of bacterial symbiontsExperientia1996 52716722

    Not in our library10.1007/bf01925581

  146. 146.

    Schmidt EW Bewley CA Faulkner DJ Theopalauamide, a bicyclic glycopeptide from filamentous bacterial symbionts of the lithistid sponge Theonella swinhoei from Palau and MozambiqueJ Org Chem1998 6312541258

    Not in our library

  147. 147.

    Bewley CA Faulkner DJ Theonegramide, an antifungal glycopeptide from the Philippine lithistid sponge Theonella swinhoeiJ Org Chem1994 5948494852

    Not in our library

  148. 148.

    Piel J Metabolites from symbiotic bacteriaNat Prod Rep2004 21519538

    Not in our library10.1039/b310175b

  149. 149.

    Piel J Hui D Wen G Butzke D Platzer M Fusetani N Matsunaga S Antitumor polyketide biosynthesis by an uncultivated bacterial symbiont of the marine sponge Theonella swinhoeiProc Natl Acad Sci2004 1011622216227

    Not in our library10.1073/pnas.0405976101

  150. 150.

    Grozdanov L Hentschel U An environmental genomics perspective on the diversity and function of marine sponge-associated microbiotaCurr Opinion Microbiol2007 10215220

    Not in our library10.1016/j.mib.2007.05.012

  151. 151.

    Bugni TS Bernan VS Greenstein M Janso JE Maiese WM Mayne CL Ireland CM Brocaenols A–C: Novel polyketides from a marine-derived Penicillium brocaeJ Org Chem2003 6820142017

    Not in our library10.1021/jo020597w

  152. 152.

    Ebel R Proksch P Müller WEG Secondary metabolites from marine-derived fungiFrontiers in Marine BiotechnologyHorizon Scientific PressNorwich, UK2006 73143

    Not in our library

  153. 153.

    Jayatilake GS Thornton MP Leonard AC Grimwade JE Baker BJ Metabolites from an Antarctic sponge associated bacterium Pseudomonas aeruginosaJ Nat Prod1996 59293296

    Not in our library10.1021/np960095b

  154. 154.

    Höller U König GM Wright AD Three new metabolites from marine derived fungi of the genera Coniothyrium and MicrosphaeropsisJ Nat Prod1999 62114118

    Not in our library10.1021/np980341e

  155. 155.

    Mohamed IE Gross H Pontius A Kehraus S Krick A Kelter G Maier A Fiebig H König GM Epoxyphomalin A and B, Prenylated Polyketides with Potent Cytotoxicity from the Marine-Derived Fungus Phoma spOrg Lett2009 1150145017

    Not in our library10.1021/ol901996g

  156. 156.

    Kralj A Gurgui M König GM van Echten-Deckert G Trichothecenes induce accumulation of glucosylceramide in neural cells by interfering with lactosylceramide synthase activityToxicol Appl Pharmacol2007 225113122

    Not in our library10.1016/j.taap.2007.08.005

  157. 157.

    Chatterjee S Kolmakova A Lactosylceramide synthase: From molecular biochemistry to biological functionLipids (sphingolipid metabolizing enzymes 2004)Research SignpostTrivandrum, India2004 3341

    Not in our library

  158. 158.

    Kralj A Kehraus S Krick A van Echten-Deckert G König GM Two new depsipeptides from the marine fungus Spicellum roseumPlanta Med2007 73366371

    Not in our library10.1055/s-2007-967131

  159. 159.

    Liu R Cui C Duan L Gu Q Zhu W Potent in Vitro anticancer activity of metacycloprodigiosin and undecylprodigiosin from a sponge-derived actinomycete Saccharopolyspora sp novArch Pharm Res2005 2813411344

    Not in our library10.1007/bf02977899

  160. 160.

    Xin ZH Zhu WM Gu QQ Fang LD Cui CB A new cytotoxic compound from Penicillium auratiogriseum, symbiotic or epiphytic fungus of sponge Mycale plumoseChin Chem Lett2005 1612271229

    Not in our library

  161. 161.

    Xin ZH Fang Y Du L Zhu T Duan L Chen J Gu Q Zhu W Aurantiomides A C, quinazoline alkaloids from the sponge-derived fungus Penicillium aurantiogriseum SP0-19J Nat Prod2007 70853855

    Not in our library10.1021/np060516h

  162. 162.

    Doshida J Hasegawa H Onuki H Shimidzu N Exophilin A, a new antibiotic from a marine microorganism Exophiala pisciphilaJ Antibiot1996 4911051109

    Not in our library10.7164/antibiotics.49.1105

  163. 163.

    Han Y Yang B Zhang F Miao X Li Z Characterization of antifungal chitinase from marine Streptomyces sp. DA11 associated with south China sea sponge Craniella australiensisMar Biotechnol2009 11132140

    Not in our library10.1007/s10126-008-9126-5

  164. 164.

    Kim TK Garson MJ Fuerst JA Marine actinomycetes related to the ‘Salinospora’ group from the Great Barrier Reef sponge Pseudoceratina clavataEnviron Microbiol2005 7509518

    Not in our library10.1111/j.1462-2920.2005.00716.x

  165. 165.

    Mincer TJ Jensen PR Kauffman CA Fenical W Widespread and persistent populations of a major new marine Actinomycete taxon in ocean sedimentsAppl Environ Microbiol2002 6850055011

    Not in our library10.1128/aem.68.10.5005-5011.2002

  166. 166.

    Kim TK Hewavitharana AK Shaw PN Fuerst JA Discovery of a new source of rifamycin antibiotics in marine sponge Actinobacteria by phylogenetic predictionAppl Environ Microbiol2006 7221182125

    Not in our library10.1128/aem.72.3.2118-2125.2006

  167. 167.

    Lafi FF Garson MJ Fuerst JA Culturable bacterial symbionts isolated from two distinct sponge species (Pseudoceratina clavata and Rhabdastrella globostellata) from the Great Barrier Reef of AustraliaMicrob Ecol2005 50213220

    Not in our library10.1007/s00248-004-0202-8

  168. 168.

    Friedrich AB Merkert H Fendert T Hacker J Proksch P Hentschel U Microbial diversity in the marine sponge Aplysina cavernicola (formerly Verongia cavernicola) analyzed by fluorescence in situ hybridization (FISH)Mar Biol1999 134461470

    Not in our library

  169. 169.

    Friedrich AB Fischer I Proksch P Hacker J Hentschel U Temporal variation of the microbial community associated with the Mediterranean sponge Aplysina aerophobaFEMS Microbiol Ecol2001 38105113

    Not in our library

  170. 170.

    Pabel CT Vater J Wilde C Franke P Hofemeister J Adler B Bringmann G Hacker J Hentschel U Antimicrobial activities and Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry of Bacillus Isolates from the marine sponge Aplysina aerophobaMar Biotechnol2003 5424434

    Not in our library10.1007/s10126-002-0088-8

  171. 171.

    Maget-Dana R Peypoux F Iturins, a special class of pore-forming lipopeptides: biological and physicochemical propertiesToxicology1994 87151174

    Not in our library10.1016/0300-483x(94)90159-7

  172. 172.

    Besson F Peypoux F Michel G Delcambe L Mode of action of iturin A, an antibiotic isolated from Bacillus subtilis on Micrococcus luteusBiochem Biophys Res Commun1978 81297304

    Not in our library10.1016/0006-291x(78)91532-2

  173. 173.

    Klich MA Lax AR Bland JM Inhibition of some mycotoxigenic fungi by iturin A, a peptidolipid produced by Bacillus subtilisMycopathologia2004 1167780

    Not in our library10.1007/bf00436368

  174. 174.

    Brauers G Edrada RA Ebel R Proksch P Wray V Berg A Grafe U Schachtele C Totzke F Finkenzeller G Marme D Kraus J Munchbach M Michel M Bringmann G Schaumann K Anthraquinones and betaenone derivatives from the sponge-associated fungus Microsphaeropsis species: Novel inhibitors of protein kinasesJ Nat Prod2000 63739745

    Not in our library10.1021/np9905259

  175. 175.

    Mackay HJ Twelves CJ Protein kinase C: a target for anticancer drugsEndocr Relat Cancer2003 10389396

    Not in our library10.1677/erc.0.0100389

  176. 176.

    Malmstroem J Christophersen C Barrero AF Oltra JE Justicia J Rosales A Bioactive metabolites from a marine-derived strain of the fungus Emericella VariecolorJ Nat Prod2002 65364367

    Not in our library10.1021/np0103214

  177. 177.

    Imamura N Nishijima M Adachi K Sano H Novel antimycin antibiotics, urauchimycins A and B, produced by marine actinomyceteJ Antibiot1993 46241246

    Not in our library10.7164/antibiotics.46.241

  178. 178.

    Yu C Curtis JM Walter JA Wright JLC Ayer SW Kaleta J Querengesser L Fathi-Afshar ZR Potent inhibitors of cysteine proteases from the marine fungus Microascus longirostrisJ Antibiot1996 49395397

    Not in our library10.7164/antibiotics.49.395

  179. 179.

    Namikoshi M Negishi R Nagai H Dmitrenok A Kobayashi H Three new chlorine containing antibiotics from a marine-derived fungus Aspergillus ostianus collected in PohnpeiJ Antibiot2003 56755761

    Not in our library10.7164/antibiotics.56.755

  180. 180.

    Kito K Ookura R Yoshida S Namikoshi M Ooi T Kusumi T Pentaketides Relating to Aspinonene and Dihydroaspyrone from a Marine-Derived Fungus Aspergillus ostianusJ Nat Prod2007 7020222025

    Not in our library10.1021/np070301n

  181. 181.

    Kito K Ookura R Yoshida S Namikoshi M Ooi T Kusumi T New Cytotoxic 14-Membered Macrolides from Marine-Derived Fungus Aspergillus ostianusOrg Lett2008 10225228

    Not in our library10.1021/ol702598q

  182. 182.

    Yoshida S Kito K Ooi T Kanoh K Shizuri Y Kusumi T 2008. Four Pimarane Diterpenes from Marine Fungus: Chloroform Incorporated in Crystal Lattice for Absolute Configuration Analysis by X-RayChem Lett2007 361386

    Not in our library

  183. 183.

    Dettrakul S Kittakoop P Isaka M Nopichai S Suyarnsestakorn C Tanticharoen M Thebtaranonth Y Antimycobacterial pimarane diterpenes from the Fungus Diaporthe spBioorg Med Chem Lett2003 1312531255

    Not in our library10.1016/s0960-894x(03)00111-2

  184. 184.

    Höller U Wright AD Matthee GF König GM Draeger S Aust H Schulz B Fungi from marine sponges: Diversity, biological activity and secondary metabolitesMycol Res2000 10413541365

    Not in our library

  185. 185.

    Müller WEG Grebenjuk VA Pennec G Schröder H Brummer F Hentschel U Müller IM Breter H Sustainable production of bioactive compounds by sponges-cell culture and gene cluster approach: A reviewMar Biotechnol2004 6105117

    Not in our library10.1007/s10126-002-0098-6

  186. 186.

    Petit KE Mondeguer F Roquebert MF Biard JF Pouches YF Detection of griseofulvin in a marine strain of Penicillium waksmanii by ion trap mass spectrometryJ Microbiol Methods2004 585965

    Not in our library10.1016/j.mimet.2004.03.004

  187. 187.

    Muth WL Nash CH III Biosynthesis of Mycophenolic acid: Purification and characterization of S-Adenosyl-L-Methionine: Demethylmycophenolic Acid O-MethyltransferaseAntimicrob Agents Chemother1975 8321327

    Not in our library10.1128/aac.8.3.321

  188. 188.

    Engel G Milczewski KE Prokopek D Teuber M Strain-specific synthesis of mycophenolic acid by P. roqueforti in blue-veined cheeseAppl Environ Microbiol1982 4310341040

    Not in our library10.1128/aem.43.5.1034-1040.1982

  189. 189.

    Sabdono A Radjasa OK Microbial symbionts in marine sponges: Marine natural product factoryJ Coast Dev2008 115761

    Not in our library

  190. 190.

    Zhang W Zhang F Li Z Miao X Meng Q Zhang X Investigation of bacteria with polyketide synthase genes and antimicrobial activity isolated from South China Sea spongesJ Appl Microbiol2009 107567575

    Not in our library10.1111/j.1365-2672.2009.04241.x

  191. 191.

    Müller WEG Brummer F Batel R Müller IM Schröder HC Molecular biodiversity. Case study: Porifera (Sponges)Naturwissenschaften2003 90103120

    Not in our library10.1007/s00114-003-0407-6

  192. 192.

    Hentschel U Usher KM Taylor MW Marine sponges as microbial fermentersFEMS Microbiol Ecol2006 55167177

    Not in our library10.1111/j.1574-6941.2005.00046.x

  193. 193.

    Hoffmann F Rapp HT Reitner J Monitoring microbial community composition by Fluorescence In situ Hybridization during cultivation of the marine cold-water sponge Geodia barrettiMar Biotechnol2006 8373379

    Not in our library10.1007/s10126-006-5152-3

  194. 194.

    Taylor MW Schupp PJ Dahllof I Kjelleberg S Steinberg PD Host specificity in marine sponge-associated bacteria, and potential implications for marine microbial diversityEnviron Microbiol2004 6121130

    Not in our library10.1046/j.1462-2920.2003.00545.x

  195. 195.

    Webster NS Negri AP Munro MMHG Battershill N Diverse microbial communities inhabit Antarctic spongesEnviron Microbiol2004 6288300

    Not in our library10.1111/j.1462-2920.2004.00570.x

  196. 196.

    Wichels A Wurtz S Dopke H Schutt C Gerdts G Bacterial diversity in the breadcrumb sponge Halichondria panacea (Pallas)FEMS Microbiol Ecol2006 56102118

    Not in our library10.1111/j.1574-6941.2006.00067.x

  197. 197.

    Thiel V Neulinger SC Staufenberger T Schmaljohann R Imhoff JF Spatial distribution of sponge-associated bacteria in the Mediterranean sponge Tethya aurantiumFEMS Microbiol Ecol2006 594763

    Not in our library10.1111/j.1574-6941.2006.00217.x

  198. 198.

    Taylor MW Schupp PJ Nys R Kjelleberg S Steinberg PD Biogeography of bacteria associated with the marine sponge Cymbastela concentricaEnviron Microbiol2005 7419433

    Not in our library10.1111/j.1462-2920.2004.00711.x

  199. 199.

    Giese AC Pearse JS Giese AC Pearse JS Introduction: general principlesReproduction of Marine Invertebrates. Vol I. Acoelomate and Pseudocoelomate MetazoansAcademic PressNew York, USA1974 149

    Not in our library

  200. 200.

    Turon X Becerro MA Uriz MJ Seasonal patterns of toxicity in benthic invertebrates: The encrusting sponge Crambe crambe (Pecilosclerida)Oikos1996 753346

    Not in our library

  201. 201.

    Thakur NL Anil AC Antibacterial activity of the sponge Ircinia ramosa: Importance of its surface-associatedbacteriaJ Chem Ecol2000 265771

    Not in our library

  202. 202.

    Imhoff JF Stohr R Sponge-associated bacteria: general overview and special aspects of bacteria associated with Halichondria paniceaProg Mol Subcell Biol2003 373557

    Not in our library10.1007/978-3-642-55519-0_2

  203. 203.

    Erpenbeck D van Soest RWM Status and perspective of sponge chemosystematicsMar Biotechnol2006 9219

    Not in our library10.1007/s10126-005-6109-7

  204. 204.

    Proksch P Edrada-Ebel R Ebel R Drugs from the Sea-Opportunities and obstaclesMar Drugs2003 1517

    Not in our library

Cited by papers we hold 10

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.